Nephrology and Hypertension, Vascular Pathology and Diabetes
Data update as of 31/12/2025

2025 DATA
Leaders
|
PIs
Research
LocationDepartment of Nephrology and Hypertension. 3rd Floor Avda. Reyes Católicos, 2. 28040 Madrid (Spain). Nephrology and Hypertension, Vascular Disease and Diabetes Laboratory Avda. Reyes Católicos, 2. 28040 Madrid (Spain).
|
Gender perspective

Summary of activities
The group carries out multidisciplinary research focused on the mechanisms, diagnosis and treatment of renal, cardiovascular and metabolic diseases. Its main strategic research lines include:
- Chronic kidney disease (CKD): identification of biomarkers of disease progression, inflammation, fibrosis and tubular injury.
- Hypertension, atherosclerosis and vascular damage: investigation of pathophysiological mechanisms, vascular remodelling, arterial stiffness and endothelial dysfunction.
- Diabetes mellitus, obesity and vascular complications: research into diabetic kidney disease, microvascular injury and associated cardiovascular risk.
- Kidney-heart-metabolism interactions: study of the integrative mechanisms linking CKD, hypertension, diabetes and cardiovascular disease.
- Precision medicine: risk stratification, genetics, proteomics and the identification of new therapeutic targets.
Contributions to society
The Group collaborates with national patient associations, including ALCER, and international organisations such as the European Kidney Patients’ Federation (EKPF), to improve the prevention, diagnosis and treatment of diabetes and renal and cardiovascular diseases.
Its contribution to society is reflected in its extensive scientific output, including more than 1,000 publications cited over 200,000 times, the development of more than 10 clinical practice guidelines, and the generation of more than 10 patents. The group is also actively involved in scientific societies and congresses and contributes to educational initiatives, including the development of the Renal MOOC and other training activities aimed at healthcare professionals, patients and the general public: https://www.edx.org/course/rinones-conoce-sus-funciones-para-mejorar-tu-salud
Collaborations
The group maintains numerous national and international collaborations within the framework of projects funded by the Spanish National R&D Plan, the European Union, and working groups belonging to national and international scientific societies. Among its main national collaborations are:
- Spanish Renal Research Network (REDINREN): participation in multicentre projects focused on chronic kidney disease, biomarkers and renal protective therapies.
- CIBERDEM and CIBERCV: collaborations on studies addressing diabetes, obesity, cardiovascular risk and inflammatory mechanisms.
- University Hospitals in the Madrid Region (La Paz University Hospital, 12 de Octubre University Hospital, Ramón and Cajal University Hospital and Clínico San Carlos University Hospital): shared patient cohorts, clinical trials and translational research projects.
- Autonomous University of Madrid (UAM): teaching activities, supervision of doctoral theses and joint biomedical research projects.
- Biomedical Research Centres (CNIC, CNIO and IMDEA): mechanistic studies on inflammation, metabolism and vascular injury.
PhD Theses

List of publications
Prevalence of primary aldosteronism and screening indications.
Ruiz-Sanchez JG.
Vitam Horm. 2026.130:43-67.
PMID: 41638804
FI: 0
http://dx.doi.org/10.1016/bs.vh.2025.08.001
Fibrillary Glomerulonephritis in Systemic Lupus Erythematosus: A Case Series.
Ayehu G, Aguirre Polo MV, Yang Y, Wu M, Jhaveri KD.
Kidney Med. 2026 Feb.8(2):101225.
PMID: 41623306
FI: 3,4
http://dx.doi.org/10.1016/j.xkme.2025.101225
The dominant driver paradigm of cardiometabolic care.
Hernandez Sevillano J, Babagoli MA, Chen Y, Liu SH, Mellacheruvu P, Johnson J, Ibanez B, Lorenzo O, Mechanick JI.
Am J Prev Cardiol. 2026 Feb.25:101389.
PMID: 41613359
FI: 5,9
http://dx.doi.org/10.1016/j.ajpc.2025.101389
From Evidence to Action: Advancing Timely Implementation of Triple Therapy in Type 2 Diabetes Mellitus and CKD.
Fernandez-Fernandez B, Gorriz JL, Cebrian-Cuenca A, Fácila L, Fernandez Rodriguez JM, Maraver MP, Ortiz A.
Kidney Int Rep. 2026 Jan.11(1):6-16.
PMID: 41541781
FI: 5,7
http://dx.doi.org/10.1016/j.ekir.2025.09.027
The Role of Aldosterone in Detecting Resistance-Driven Hypoaldosteronism and Deficit-Driven Hypoaldosteronism.
Ruiz-Sánchez JG, Calle-Pascual AL, Rubio-Herrera MÁ, De Miguel Novoa P, Gómez-Hoyos E, Runkle I.
J Clin Med. 2025 Dec 27.15(1).
PMID: 41517465
FI: 2,9
http://dx.doi.org/10.3390/jcm15010218
A Pilot Study of Opportunistic Chronic Kidney Disease Screening in Primary Care Using a Clinical Decision Support System.
López-Garrigós M, Puig E, Sánchez S, Gutiérrez I, Salinas M, Ortiz A, Flores E.
Diagnostics (Basel). 2025 Dec 19.16(1).
PMID: 41515503
FI: 3,3
http://dx.doi.org/10.3390/diagnostics16010008
The association between mineralocorticoid receptor antagonist use and diabetes occurrence and progression: A systematic review and meta-analysis.
Kanbay M, Guldan M, Ozbek L, Rustamov A, Gulmaliyev I, Ortiz A, Rossing P.
Br J Clin Pharmacol. 2025 Dec 30.
PMID: 41469771
FI: 3
http://dx.doi.org/10.1002/bcp.70433
Comparing Age and Sex Specific Reference Values of Estimated Glomerular Filtration Rate between the United States and Europe.
Astley ME, Ortiz A, Hallan S, Gambaro G, Carrero JJ, Ebert N, Eriksen BO, Faucon AL, Ferraro PM, Ittermann T, Indridason OS, Rise Langlo KA, Melsom T, Rule AD, Schaeffner E, Stracke S, Palsson R, Jager KJ, Stel VS, Chesnaye NC.
Clin J Am Soc Nephrol. 2025 Dec 26.
PMID: 41452663
FI: 7,1
http://dx.doi.org/10.2215/CJN.0000000956
Safeguarding Innovation in Dialysis-Rethinking the EU Medical Device Regulation.
Ferreira AC, Sezer S, Palladino G, Ortiz A.
Nephrol Dial Transplant. 2025 Dec 22.
PMID: 41427891
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf270
Adherence to the Mediterranean Diet and frailty criteria in an old population with metabolic syndrome: A cross-sectional analysis.
Torrego-Ellacuría M, Cuesta-Triana F, Ortiz-Ramos M, Martínez-González MÁ, Corella D, Vázquez-Lorente H, Fitó M, Martínez JA, Tojal-Sierra L, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Santos-Lozano JM, Serra-Majem JL, Bueno-Cavanillas A, Tur JA, Romero Vigara JC, Pintó X, Gaforio JJ, Vidal J, Mas-Fontao S, Daimiel L, Chiva-Blanch G, Basterra-Gortari J, Gutierrez L, Sorlí JV, Minguella Muñoz E, García-Rios A, Bernabé Casanovas A, Gómez-Gracia E, Zulet MA, Nafría M, Casas R, Garrido-Garrido EM, Goicolea-Güemez L, Gómez-Pérez AM, Ruiz-Canela M, Megias I, Valero-Barceló C, Montenegro Calvo M, Peña-Orihuela PJ, Tercero Maciá C, Razquín C, Babio N, Sala de Vedruna A, Barabash A, Matía-Martín P.
J Nutr Health Aging. 2025 Dec 17.30(2):100757.
PMID: 41411872
FI: 4
http://dx.doi.org/10.1016/j.jnha.2025.100757
Gut microbiota modulation in GLP-1RA and SGLT-2i therapy: clinical implications and mechanistic insights in type 2 diabetes.
Kanbay M, Al-Shiab R, Shah E, Ozbek L, Guldan M, Ortiz A, Fouque D.
Clin Kidney J. 2025 Dec.18(12):sfaf351.
PMID: 41409228
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf351
Understanding frailty across the kidney transplant continuum: a comprehensive systematic review of recent evidence.
Kanbay M, Fidan DG, Guldan M, Ozbek L, Abdel-Rahman SM, Ortiz A, Covic A.
Int Urol Nephrol. 2025 Dec 16.
PMID: 41402678
FI: 1,9
http://dx.doi.org/10.1007/s11255-025-04968-3
Ovarian metastasis in a young woman with follicular thyroid carcinoma: A differential diagnosis with struma ovarii.
Tejedo-Flors D, Argüello-Gordillo T, Argente-Martínez E, López-Muñoz B, López-Mondéjar P.
Endocrinol Diabetes Nutr (Engl Ed). 2025 Dec 13:501676.
PMID: 41391968
FI: 1,8
http://dx.doi.org/10.1016/j.endien.2025.501676
Second edition of the "do not do"" recommendations from the Spanish Society of Endocrinology and Nutrition (SEEN).
Díez JJ, Gargallo Fernández M, Gimeno Orna JA, González Arnaiz E, Huguet Moreno I, Martínez Couselo S, Miguélez González M, Ocón MJ, Pérez López G, Pita Gutiérrez F, Reverter Calatayud JL, Tejera Pérez C, Urgell Rull E, Fernández A.
Endocrinol Diabetes Nutr (Engl Ed). 2025 Dec 13:501687.
PMID: 41391967
FI: 1,8
http://dx.doi.org/10.1016/j.endien.2025.501687
OBE-DIGITHUM: A Clinician-Led Digital Pathway for Sustainable Obesity Care-A Perspective.
Montoya T, Cárdenas JJ, Luca BL, Paniagua A, García-Valdecasas L, Reigosa L, Cruz S, Mas-Fontao S, Sierra R, Pérez de Arenaza V, Aganzo M, Gómez-Meana Á, Izquierdo I, Vázquez C.
Obes Rev. 2025 Dec 02:e70042.
PMID: 41330569
FI: 7,4
http://dx.doi.org/10.1111/obr.70042
Understanding the social dimensions of kidney care pathways: A scoping review protocol.
Anokye R, Larkin J, Fehintola A, Eustace-Cook J, Martínez-Cadenas R, Duane B, Johnston B.
PLoS One. 2025.20(10):e0335597.
PMID: 41171735
FI: 2,6
http://dx.doi.org/10.1371/journal.pone.0335597
Fish-eye disease. Altered HDL cholesterol metabolism and corneal involvement: A case report.
Álvarez ODogherty A, Rodríguez Jiménez C, Belanger-Quintana A, Rodríguez Novoa S, Arrieta Blanco F.
Endocrinol Diabetes Nutr (Engl Ed). 2025 Dec.72(10):501638.
PMID: 41102068
FI: 1,8
http://dx.doi.org/10.1016/j.endien.2025.501638
Morphofunctional parameters as predictors of autologous hematopoietic stem cell transplantation outcomes.
Cornago J, Dassen C, Calderón C, Mahíllo I, Pardo L, López-Lorenzo JL, Hormigo AI, Caballero JC, Domingo-González A, Capellán R, Iturrate I, de Camino BP, Sánchez-Fernández MS, Teixeira Á, Del Pecho M, Llamas P, Solán L.
Front Nutr. 2025.12:1666754.
PMID: 41080170
FI: 5,1
http://dx.doi.org/10.3389/fnut.2025.1666754
Clinical factors influencing the systolic blood pressure benefits of once-weekly semaglutide in patients with type 2 diabetes.
Ruiz-Sánchez JG, Sierra Poyatos RM, Luiza Luca B, Sánchez-Lechuga B, Modroño Móstoles N, Montoya Álvarez T, Meneses D, Sánchez-Lopez R, Casado Cases C, Pérez de Arenaza Pozo V, Vázquez C, Cárdenas-Salas JJ.
Med Clin (Barc). 2025 Dec.165(6):107179.
PMID: 41014747
FI: 2,1
http://dx.doi.org/10.1016/j.medcli.2025.107179
Multidisciplinary Delphi study on residual risk in patients with chronic kidney disease and type 2 diabetes mellitus.
Ortiz A, Cebrián A, Soto A, Reyes A, Górriz JL.
Nefrologia (Engl Ed). 2025.45(7):501338.
PMID: 40945994
FI: 2,6
http://dx.doi.org/10.1016/j.nefroe.2025.501338
Sex differences in (poly)phenol intake patterns and cardiovascular risk in Spanish adult population at high risk of cardiovascular disease: Cross-sectional findings.
Rubín-García M, Vitelli-Storelli F, Toledo E, Álvarez-Álvarez L, Martínez-González MÁ, Corella D, Salas-Salvadó J, Zomeño MD, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Santos-Lozano JM, Serra-Majem L, Bueno-Cavanillas A, Tur JA, Pintó X, Gaforio JJ, Matía-Martín P, Vidal J, Mas-Fontao S, Daimiel L, Ros E, Vázquez-Ruiz Z, Fernández de la Puente M, Álvarez-Sala A, Pérez-Vega A, García-Rios A, González-Palacios S, Gómez-Pérez AM, Zulet MÁ, Chaplin A, Casas R, Cano-Ibañez N, Tojal-Sierra L, Cueto-Galán R, Buil-Cosiales P, Gutiérrez-Carrasquilla L, Sorli JV, Malcampo M, Ortiz-Morales AM, Mira-Castejón LA, Rios S, Fitó M, Martín-Sánchez V, PREDIMED-PLUS Trial Investigators.
Nutrition. 2025 Dec.140:112919.
PMID: 40876090
FI: 3
http://dx.doi.org/10.1016/j.nut.2025.112919
Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response.
Rochano-Ortiz A, San Sebastián-Jaraba I, Zamora C, Simó C, García-Cañas V, Martínez-Albaladejo S, Fernández-Gómez MJ, Marcos-Ríos D, Martínez-Núñez P, Martín-Lorenzo M, Velho TR, Ruíz-Rodríguez MJ, Leal-Zafra A, Gabandé-Rodríguez E, Martínez-Martínez S, Guala A, Lorenzo Ó, Blanco-Colio LM, Martín-Ventura JL, Álvarez-Llamas G, Aldamiz-Echevarría G, Teixidó-Tura G, Forteza A, Nistal JF, Redondo JM, Méndez-Barbero N, Mittelbrunn M, Oller J.
Eur Heart J. 2025 Dec 01.46(45):4988-5005.
PMID: 40720766
FI: 35,7
http://dx.doi.org/10.1093/eurheartj/ehaf556
Frailty Prevalence and Characterization Among Kidney Transplant Candidates in Spain: A Multicenter Study.
Pérez-Sáez MJ, Melilli E, Arias M, Franco A, Martínez R, Sancho A, Molina M, Facundo C, Polanco N, López V, Mazuecos A, Cabello S, González García ME, Suárez ML, Auyanet I, Espi J, García Falcón T, Ruiz JC, Galeano C, Artamendi M, Rodríguez-Ferrero ML, Portolés JM, Santana MA, Martín-Moreno PL, Arhda N, Calvo M, Mendiluce A, Macía M, Pérez-Tamajón ML, de Teresa J, Gascó B, Soriano S, Tabernero G, de la Vara L, Ramos AM, Martínez R, Montero de Espinosa E, Zalve JL, Pascual J, Rodríguez-Mañas L, Gutiérrez-Dalmau A, Moreso F.
Transpl Int. 2025.38:14098.
PMID: 40630784
FI: 3
http://dx.doi.org/10.3389/ti.2025.14098
Aging with HIV: a cross-sectional look at comorbidities.
Montes MC, Rueda-Camino JA, Rallón N, Nistal-Juncos S, Barba Martín R.
Rev Clin Esp (Barc). 2025.225(6):502310.
PMID: 40348277
FI: 1,7
http://dx.doi.org/10.1016/j.rceng.2025.502310
Hyperinflammation and Blindness. Screening for ROSAH Syndrome.
Tornero-Romero F, Sánchez-Hernandez R, Cantero-Del Olmo L, Saravia-Moya A, Gonzalez de Rivera-Utrera M, Sánchez-Barbero AI, Carreño-Salas E.
Eur J Case Rep Intern Med. 2025.12(4):004989.
PMID: 40270650
FI: 0
http://dx.doi.org/10.12890/2025_004989
Nomenclature of renal involvement in diabetes mellitus: unify to manage diversity.
Marques M, Portolés J, Mora-Fernández C, Ortiz A, Navarro-González JF.
Front Med (Lausanne). 2025.12:1533011.
PMID: 40134917
FI: 3
http://dx.doi.org/10.3389/fmed.2025.1533011
Diabetes Mellitus and Chronic Kidney Disease: The Future Is Being Surpassed.
Martínez-Castelao A, Górriz JL, Fernández-Fernández B, Soler MJ, Navarro-González JF.
J Clin Med. 2025 Nov 23.14(23).
PMID: 41375628
FI: 2,9
http://dx.doi.org/10.3390/jcm14238326
Implementation of cervical ultrasound and related techniques in endocrinology and nutrition services in Spain. ECOSEEN 2025 study.
Reverter JL, Díaz Soto G, Martin T, Gargallo M, Sambo M, Argüelles I, Imaging and Associated Techniques Group of the Spanish Society of Endocrinology and Nutrition.
Endocrinol Diabetes Nutr (Engl Ed). 2025 Nov 26:501659.
PMID: 41309328
FI: 1,8
http://dx.doi.org/10.1016/j.endien.2025.501659
Feasibility and Acceptability of the Cancer-Specific PRONTO Protocol for Nutritional Risk Screening in Outpatient Oncology Cancer Care: A Pilot Study.
Sánchez-Cabrero D, Rubio J, Durá Esteve J, Guzmán-Gómez L, Guzmán-Rolo G, Grande C, Martín Aguilar A, Pérez-Wert P, Pertejo A, Sulo S, Sharn AR, Palma Milla S, Dassen C, Muscaritoli M.
Cancers (Basel). 2025 Nov 19.17(22).
PMID: 41301062
FI: 4,4
http://dx.doi.org/10.3390/cancers17223697
Historical Control Analysis Demonstrates Greater Long-Term Reduction in Plasma Globotriaosylceramide (Gb3) by Venglustat Compared With Placebo or Agalsidase Beta in Male Patients With Classic Fabry Disease.
Germain DP, DasMahapatra P, Liu S, Deegan P, Ortiz A, Modur V, Wilcox WR.
Mol Genet Genomic Med. 2025 Nov.13(11):e70152.
PMID: 41246852
FI: 1,6
http://dx.doi.org/10.1002/mgg3.70152
Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions.
Kopytina V, Marchant V, Rodrigues-Diez R, Pascual-Antón L, Toggweiler N, Strahl L, Kane J, Tejera-Muñoz A, Cortés M, Sucunza D, Vaquero JJ, Vervloet M, Piecha D, Eringa EC, Ruiz-Ortega M, López-Cabrera M, González-Mateo GT.
Nephrol Dial Transplant. 2025 Nov 13.
PMID: 41231614
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf249
Nutritional Strategies to Address Malnutrition in Dialyses Patients: A Systematic Review.
Arroyo-Serrano P, Alonso-Dominguez R, Mas-Fontao S, Gonzalez-Parra E, Sánchez-Tocino ML.
Nutrients. 2025 Nov 05.17(21).
PMID: 41228549
FI: 5
http://dx.doi.org/10.3390/nu17213478
Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Chronic Kidney Disease Collaborators(Ortiz A).
Lancet. 2025 Nov 22.406(10518):2461-2482.
PMID: 41213283
FI: 88,5
http://dx.doi.org/10.1016/S0140-6736(25)01853-7
New Kidneys, Old Risks: Cardiovascular Challenges After Transplantation.
Van Craenenbroeck AH, Chinnappa S, Dounousi E, Fernandez-Fernandez B, Iatridi F, Mark PB, Piko N, Stegbauer J, Torino C, Vogt L, Valdivielso JM.
Nephrol Dial Transplant. 2025 Nov 06.
PMID: 41206563
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf239
The importance of disease coding following the diagnosis of chronic kidney disease: From ICD-10 code N18.9 to the role of clinical laboratories.
Troya MI, Bover J, Cia Hidalgo A, Malumbres S, Sánchez-Bayá M, Massó E, Coll-Brito V, Anton-Pampols P, da Silva I, Soler-Majoral J, Marcos E, Moreiras Abril B, Pérez-León N, Morera García M, Golf Zaragoza JP, Jusmet Miguel X, Lejardi Estevez Y, López-Alarcón R, Blanco I, Morales Indiano C, Gràcia-Garcia S, Buño Soto A, Górriz JL, Buades JM, Ortiz A, Sánchez E, Ara J.
Nefrologia (Engl Ed). 2025 Nov.45(9):501410.
PMID: 41203527
FI: 2,6
http://dx.doi.org/10.1016/j.nefroe.2025.501410
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both: Post Hoc Analyses of CONFIDENCE Trial.
Mottl A, Scott C, Green JB, Heerspink HJL, Mann JFE, McGill JB, Nangaku M, Rosenstock J, Rossing P, Li L, Li N, Vaduganathan M, Agarwal R, CONFIDENCE Trial Investigators(Ortiz A).
J Am Soc Nephrol. 2025 Nov 06.
PMID: 41196655
FI: 9,4
http://dx.doi.org/10.1681/ASN.0000000928
Kidney replacement therapy trajectories of patients with kidney failure: an ERA Registry study.
Boerstra BA, Kramer A, Jager KJ, Arnol M, Åsberg A, Bakkaloglu SA, Buchwinkler L, Crespo M, Ten Dam MAGJ, Finne P, García-Marcos SA, Heylen L, Hommel K, Indridason OS, Kuzema V, Lanot A, Methven S, Mutevelić-Turković A, Ponte B, Arévalo OLR, Valentin MO, Ortiz A, Stel VS, Ferraro PM.
Nephrol Dial Transplant. 2025 Nov 03.
PMID: 41183509
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf236
Counterreply to the letter ""About the study of geriatric syndromes: the definition matters"".
Montes MC, Rueda-Camino JA, Rallón N, Nistal-Juncos S, Barba-Martín R.
Rev Clin Esp (Barc). 2025 Nov.225(9):502385.
PMID: 41167423
FI: 1,7
http://dx.doi.org/10.1016/j.rceng.2025.502385
Trends in pulmonary embolism incidence in Spain (2016-2022): an analysis of differences among autonomous communities.
Gimena-Rodríguez FJ, Barba-Martín R, Angelina-García M, Trujillo-Luque D, Joya-Seijo MD, Rueda-Camino JA.
Rev Clin Esp (Barc). 2025 Nov.225(9):502377.
PMID: 41138975
FI: 1,7
http://dx.doi.org/10.1016/j.rceng.2025.502377
Albuminuria-based universal screening for CKD should be implemented now in high-income countries.
Cordero L, Ortiz A.
Kidney Int. 2025 Nov.108(5):754-759.
PMID: 40907890
FI: 12,6
http://dx.doi.org/10.1016/j.kint.2025.04.037
Impact of the Type of Dialysate Acid Concentrate Container on the Environmental Footprint of Hemodialysis Centers.
Martínez-Cadenas R, Audije-Gil J, Arenas MD, Vaquero NM, Portillo J, Larkin J, Fehintola A, Ortiz A, Duane B.
Am J Kidney Dis. 2025 Nov.86(5):616-623.e1.
PMID: 40738182
FI: 8,8
http://dx.doi.org/10.1053/j.ajkd.2025.06.009
Circulating and Urinary CCL20 in Human Kidney Disease.
Molina-Cazallas N, García-Ayuso D, Fernández-Fernández B, Rodríguez-Osorio L, Sanchez-Rodriguez J, Pérez-Gómez MV, Ortiz A, Ramos AM.
Int J Mol Sci. 2025 Oct 30.26(21).
PMID: 41226600
FI: 4,9
http://dx.doi.org/10.3390/ijms262110563
Exploring the Challenges and Opportunities of ChatGPT in University Teaching for Health Sciences: A Narrative Review.
Arroyo-Bello E, González-Toledo B, Abad-Valle J, Rodríguez-Gómez P, Garrigues-Ramón M.
Cureus. 2025 Oct.17(10):e94259.
PMID: 41216045
FI: 1,3
http://dx.doi.org/10.7759/cureus.94259
Time trends in home dialysis: ERA Registry Figure of the month.
Stel VS, Ortiz A, Kramer A.
Clin Kidney J. 2025 Oct.18(10):sfaf325.
PMID: 41190265
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf325
Kidney replacement therapy for men and women according to the ERA Registry and the USRDS.
Stel VS, Chesnaye NC, Boenink R, Boerstra BA, Astley ME, Methven S, Heylen L, Resic H, Ten Dam MAGJ, Hommel K, Solbu MD, Roblero MFS, Aresté-Fosalba N, Radunovic D, López HG, Buchwinkler L, Guidotti R, Lassalle M, Santiuste C, Stendahl M, Indridason OS, Escribá A, Bouzas-Caamaño ME, Arévalo OLR, Moustakas G, Vargas HH, Ortiz A, Kramer A.
Nephrol Dial Transplant. 2025 Oct 31.
PMID: 41172240
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf233
Impact of switching from the CKD-EPI2009 to the EKFC equation on the epidemiology of chronic kidney disease and nephrology workload.
Villalvazo P, Molinero-Casares LM, Ortiz A.
Clin Kidney J. 2025 Oct.18(10):sfaf278.
PMID: 41158188
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf278
Bridging the gap: recommendations to accomplish transition from pediatric to adult care in adolescents living with obesity.
Goday A, Pérez G, Fernández A, Díaz-Carrasco X, Leis R, de Hollanda A, Ramon-Krauel M.
Rev Endocr Metab Disord. 2025 Oct 21.
PMID: 41118079
FI: 8
http://dx.doi.org/10.1007/s11154-025-09998-x
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Causes of Death Collaborators(Ortiz A).
Lancet. 2025 Oct 18.406(10513):1811-1872.
PMID: 41092928
FI: 88,5
http://dx.doi.org/10.1016/S0140-6736(25)01917-8
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Demographics Collaborators(Ortiz A).
Lancet. 2025 Oct 18.406(10513):1731-1810.
PMID: 41092927
FI: 88,5
http://dx.doi.org/10.1016/S0140-6736(25)01330-3
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Disease and Injury and Risk Factor Collaborators.
Lancet. 2025 Oct 18.406(10513):1873-1922.
PMID: 41092926
FI: 88,5
http://dx.doi.org/10.1016/S0140-6736(25)01637-X
Mineralocorticoid receptor antagonist pre-adrenalectomy in primary aldosteronism.
Goi J, Paja Fano M, Rizo Gellida A, González-Boillos M, Martín Rojas-Marcos P, Caja Guayerbas L, García Cano AM, Ruiz-Sanchez JG, Vicente A, Gómez-Hoyos E, Recasens M, Barahona San Millan R, Picón César MJ, Díaz Guardiola P, Perdomo CM, Manjón-Miguélez L, Rebollo Román Á, Robles Lázaro C, Recio-Cordova JM, Calatayud M, Jiménez López N, Sampedro Nuñez M, Mena Ribas E, Sanmartín Sánchez A, Gonzalvo Diaz C, Lamas C, Serrano J, Michalopoulou T, Tenes Rodrigo S, Pascual-Corrales E, Jaén Aguila F, Muñoz Rivas N, Moya Mateo EM, Gutiérrez-Medina S, Hanzu FA, Parra Ramírez P, Araujo-Castro M.
J Clin Endocrinol Metab. 2025 Oct 04.
PMID: 41045519
FI: 5,1
http://dx.doi.org/10.1210/clinem/dgaf545
Urinary tartaric acid and cardiovascular disease risk.
Ortiz A.
Eur Heart J. 2025 Oct 03.
PMID: 41042973
FI: 35,7
http://dx.doi.org/10.1093/eurheartj/ehaf760
Comorbidity and Malnutrition as Key Determinants of Mortality in Elderly Haemodialysis Patients: A One-Year Observational Study.
Sanchez-Tocino ML, Mas-Fontao S, González-Parra E, Manso P, Burgos M, Carneiro D, Pereira M, Pereira C, Lopez-González A, Arenas MD, on behalf the renal foundation work team.
J Cachexia Sarcopenia Muscle. 2025 Oct.16(5):e70062.
PMID: 40990164
FI: 9,1
http://dx.doi.org/10.1002/jcsm.70062
Attention deficit hyperactivity disorder risk, mental health diagnoses and experience of discrimination in transgender adolescents and youth.
Martínez Del Río C, Cuellar-Flores I, López de Lara D, Castañeda-Vozmediano R, Miguélez González M, Gaitero Pérez A, Pérez Rodríguez O, García Ron A.
Endocrinol Diabetes Nutr (Engl Ed). 2025 Oct.72(8):501593.
PMID: 40946028
FI: 1,8
http://dx.doi.org/10.1016/j.endien.2025.501593
Rapidly Growing Thyroid Masses in Adults: Urgent Diagnostic Challenges and Effective Management-Single-Center Experience and Literature Review.
Miguélez González M, Fernández Sánchez Á, Álvarez Álvarez MB, Quiceno Arias HD, Osorio Silla I.
World J Surg. 2025 Oct.49(10):2777-2781.
PMID: 40879557
FI: 2,5
http://dx.doi.org/10.1002/wjs.70063
STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis.
Marchant V, García-Giménez J, González-Mateo GT, Sandoval P, Tejedor-Santamaria L, Rayego-Mateos S, Ramos R, Jiménez-Heffernan JA, Ortiz A, Raby AC, López-Cabrera M, Ramos AM, Ruiz-Ortega M.
J Pathol. 2025 Oct.267(2):196-212.
PMID: 40810380
FI: 5,2
http://dx.doi.org/10.1002/path.6462
The environmental and genetic architectures of ageing and CKD.
Sanchez-Niño MD, Byrska JK, Ortiz A.
Nephrol Dial Transplant. 2025 Oct 30.40(11):2008-2010.
PMID: 40794941
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf146
Differences in histopathologic features and diagnostic performance of 99mTc-methoxy-isobutyl-isonitrol single photon emission tomography-CT and 18F-fluorocholine positron emission tomography-CT in primary hyperparathyroidism.
Osorio-Silla I, González DM, Quiceno Arias HD, Peinado PP, Cárdenas Salas JJ, González MM, Pestana Soares CA, Martínez Ruiz LF, Landaeta Kancev LC, Dhier LM, Escanciano M, Sánchez de Molina ML, Ruíz AP, Campos PV.
Surgery. 2025 Oct.186:109595.
PMID: 40782725
FI: 2,7
http://dx.doi.org/10.1016/j.surg.2025.109595
10 tips on how to take a proper family history in CKD patient care.
Cornec-Le Gall E, van Eerde AM, Figueres L, Simons M, Capasso G, Perez Gomez MV, Nijenhuis T, Sayer JA, Zagorec N, Müller RU, Halbritter J.
Clin Kidney J. 2025 Sep.18(9):sfaf253.
PMID: 41140976
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf253
Time trends in preemptive kidney transplantation in Europe: ERA Registry Figure of the month.
Stel VS, Ortiz A, Kramer A.
Clin Kidney J. 2025 Sep.18(9):sfaf304.
PMID: 41080616
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf304
Finerenone: Evidence for benefit in Early Stages of Cardiovascular-Kidney-Metabolic Syndrome.
Márquez DF, Ortiz A, González-Moreno D, Ruilope LM, Ruiz-Hurtado G.
Cardiorenal Med. 2025 Sep 25:1-15.
PMID: 41036653
FI: 2,9
http://dx.doi.org/10.1159/000548494
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysis.
Duane B, Larkin J, Caiazzo M, Arenas M, Griffin A, Audije-Gil J, Mortimer F, Attwell H, Yasar A, Martínez-Cadenas R, Arias-Guillén M, Gomez M, Fehintola A, Steinbach I, Ortiz A.
Clin Kidney J. 2025 Sep.18(9):sfaf220.
PMID: 41030566
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf220
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
Cordero L, Abasheva D, Ortiz A.
N Engl J Med. 2025 Sep 25.393(12):1246-1247.
PMID: 40991917
FI: 78,5
http://dx.doi.org/10.1056/NEJMc2511206
Increased tumor necrosis factor-receptor superfamily plasma levels are associated with early renal or retinal involvement in intermediate hyperglycemia.
Mas-Fontao S, Civantos E, Boukichou-Abdelkader N, Moreno JA, Gomez-Guerrero C, Gálvez MIL, Tuomilehto J, Lind M, Gabriel R, Egido J.
World J Diabetes. 2025 Sep 15.16(9):106002.
PMID: 40980291
FI: 4,6
http://dx.doi.org/10.4239/wjd.v16.i9.106002
Transition of patients with hereditary nephropathies from pediatric to adult care.
Gomez MVP, Costea GC, Claus L, Gall EC, van Eerde AM, Lemoine S, Groothoff J, Levtchenko E, Klein L, Pape L, Müller RU, Liebau MC.
Nephrol Dial Transplant. 2025 Sep 10.
PMID: 40928490
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf186
Plasma Interleukin 22 Predicts Progression of Early Diabetic Kidney Disease.
Fernandez-Fernandez B, Hasegawa T, Saruta Y, Li Guan Y, Sanz AB, Sanchez-Niño MD, Ramos AM, Sanchez-Rodriguez J, Navarro-Gonzalez JF, Ortiz A.
Am J Nephrol. 2025 Sep 08:1-13.
PMID: 40920595
FI: 3,2
http://dx.doi.org/10.1159/000547738
Identification of early predictors of clinical remission in primary membranous nephropathy: a post hoc analysis of the STARMEN trial.
Rojas-Rivera JE, Caravaca-Fontán F, van de Logt AE, Sevillano A, Shabaka A, Ávila A, Rabasco C, Cabello V, Ortiz A, Quintana LF, Goicoechea M, Diaz M, Ronco P, Wetzels J, Fernández-Juárez G, Praga M.
Clin Kidney J. 2025 Sep.18(9):sfaf256.
PMID: 40900938
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf256
Phthalate exposure is associated with subclinical coronary atherosclerosis: The Aragon Workers' Health Study (AWHS).
Mérida DM, Torrijo-Belanche C, Moreno-Franco B, Laclaustra M, Rey-García J, Gimeno-Ruiz S, Bayán-Bravo A, Guallar-Castillón P.
Am J Prev Cardiol. 2025 Sep.23:101072.
PMID: 40831762
FI: 5,9
http://dx.doi.org/10.1016/j.ajpc.2025.101072
Trends in Home Dialysis Over the Last Decade in Europe: an ERA Registry Study.
Slon-Roblero MF, Stel VS, Sanchez-Alvarez E, Escola JM, Dias BJF, Auñón AS, Ferraro PM, De Meester JM, Boyer A, Rydell H, Hommel K, Åsberg A, Arias IR, Methven S, Huete MJE, Abrahams AC, Palsson R, Goffin E, Aresté-Fosalba N, Bello AJ, Kuzema V, Helve J, Kerschbaum J, Bakkaloglu SA, Kislikova M, Jager KJ, Ortiz A, Kramer A.
Nephrol Dial Transplant. 2025 Aug 29.
PMID: 40880108
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf171
67 national-level factors potentially related to the incidence of kidney replacement therapy across Europe.
Pella E, Boenink R, Kramer A, Jager KJ, Ortiz A, Stel VS.
Nephrol Dial Transplant. 2025 Aug 28.
PMID: 40874760
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf163
Association Between Oxidative-Inflammation Biomarkers and Incident Chronic Kidney Disease in People with High Cardiovascular Risk: A Nested Case-Control Study.
Quetglas-Llabrés MM, Díaz-López A, Bouzas C, Monserrat-Mesquida M, Salas-Salvadó J, Ruiz-Canela M, Martínez JA, Santos-Lozano JM, García S, Estruch R, López-Miranda J, Romaguera D, Tinahones FJ, García-Fernández M, Mas-Fontao S, Matía-Martín P, Vioque J, Bueno A, Babio N, Tur JA, Sureda A.
Antioxidants (Basel). 2025 Aug 08.14(8).
PMID: 40867871
FI: 6,6
http://dx.doi.org/10.3390/antiox14080975
Varying mortality risks among patients with primary glomerular disease starting kidney replacement therapy: ERA Registry Figure of the month.
Stel VS, Ortiz A, Kramer A.
Clin Kidney J. 2025 Aug.18(8):sfaf237.
PMID: 40861383
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf237
Comparison of an Energy-Reduced Mediterranean Diet and Physical Activity Versus an Ad Libitum Mediterranean Diet in the Prevention of Type 2 Diabetes : A Secondary Analysis of a Randomized Controlled Trial.
Ruiz-Canela M, Corella D, Martínez-González MÁ, Babio N, Martínez JA, Forga L, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Santos-Lozano JM, Serra-Majem L, Bueno-Cavanillas A, Tur JA, Martín-Sánchez V, Riera-Mestre A, Delgado-Rodríguez M, Matía-Martín P, Vidal J, Vázquez C, Daimiel L, Buil-Cosiales P, Shyam S, Sorlí JV, Castañer O, García-Rios A, Torres-Collado L, Gómez-Gracia E, Zulet MÁ, Konieczna J, Casas R, Cano-Ibáñez N, Tojal-Sierra L, Bernal-López RM, Toledo E, García-Gavilán J, Fernández-Carrión R, Goday A, Arenas-Larriva AP, González-Palacios S, Schröder H, Ros E, Fitó M, Hu FB, Tinahones FJ, Salas-Salvadó J.
Ann Intern Med. 2025 Aug 26.
PMID: 40854218
FI: 15,4
http://dx.doi.org/10.7326/ANNALS-25-00388
In silico prediction of optimal multifactorial intervention in chronic kidney disease.
Latosinska A, Mina IK, Nguyen TMN, Golovko I, Keller F, Mayer G, Rossing P, Staessen JA, Delles C, Beige J, Glorieux G, Clark AL, Schanstra JP, Vlahou A, Peter K, Rychlík I, Ortiz A, Campbell A, Rupprecht H, Persson F, Mischak H, Siwy J.
J Transl Med. 2025 Aug 21.23(1):943.
PMID: 40842026
FI: 7,5
http://dx.doi.org/10.1186/s12967-025-06977-3
How to interpret the number needed to treat for clinicians.
Chesnaye NC, Ortiz A, van Diepen M, Dekker F, Zoccali C, Tripepi G, Jager KJ, Stel VS.
Nephrol Dial Transplant. 2025 Aug 21.
PMID: 40839106
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf168
Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.
Burgos E, Fernández Fernández B, Ortiz A.
N Engl J Med. 2025 Aug 14.393(7):725-726.
PMID: 40802954
FI: 78,5
http://dx.doi.org/10.1056/NEJMc2507996
Effects of oral semaglutide on kidney outcomes in people with type 2 diabetes: a nationwide, multicentre, retrospective, observational study (Renal_ENDO2S-RWD substudy).
Moreno-Pérez O, Reyes-Garcia R, Guillen-Morote C, Doulatram-Gamgaram VK, Casado Cases C, Arias Mendoza N, Tejera-Pérez C, Cárdenas-Salas J, Martínez-Fuster S, Lardiés-Sánchez B, Márquez-Pardo R, Pinés P, Tejera-Muñoz A, Fernández-García JC, Modrego-Pardo I.
Clin Kidney J. 2025 Aug.18(8):sfaf227.
PMID: 40800212
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf227
Changing from the CKD-EPI to the EKFC creatinine equation to estimate glomerular filtration rate in adults in a Northern European health system.
Russel WA, Fu EL, Creon A, Faucon AL, Caldinelli A, Bouwmans P, Inker LA, Delanaye P, Pottel H, Ortiz A, Levey AS, Carrero JJ.
Nephrol Dial Transplant. 2025 Aug 11.
PMID: 40796100
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf148
Evolving strategies for early diagnosis, proactive prevention and treatment of CKD.
Ortiz A, Yanagita M, Yokoi H, Torra R.
Nephrol Dial Transplant. 2025 Aug 08.
PMID: 40795360
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf151
From pathophysiology to novel approaches for obesity-associated hypertension.
Kanbay M, Yayci E, Genc C, Copur S, Aktas O, Sarafidis P, Covic A, Ortiz A, Laffin LJ.
Clin Kidney J. 2025 Aug.18(8):sfaf218.
PMID: 40761303
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf218
Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Kidney Failure with Replacement Therapy Collaborators(Ortiz A).
Lancet Glob Health. 2025 Aug.13(8):e1378-e1395.
PMID: 40712611
FI: 18
http://dx.doi.org/10.1016/S2214-109X(25)00198-6
Sex-based differences in access to reperfusion therapies for pulmonary embolism in Spain during the 2016-2022 period.
Rueda-Camino JA, Angelina-García M, Trujillo-Luque D, Joya-Seijo MD, Teigell-Prieto L, Novalbos-Partida JÁ, Gimena-Rodríguez FJ, Barba-Martín R.
Thromb Res. 2025 Aug.252:109371.
PMID: 40479910
FI: 3,4
http://dx.doi.org/10.1016/j.thromres.2025.109371
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl AK, Rosenstock J, Rossing P, Vaduganathan M, Brinker M, Edfors R, Li N, Scheerer MF, Scott C, Nangaku M, CONFIDENCE Investigators(Ortiz A).
N Engl J Med. 2025 Aug 07.393(6):533-543.
PMID: 40470996
FI: 78,5
http://dx.doi.org/10.1056/NEJMoa2410659
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease.
Bakker WM, Heerspink HJL, Berger SP, Wanner C, Badve SV, Arnott C, Abrahams AC, van den Born JC, van Faassen TC, Gaillard CAJM, Gelens MACJ, Górris JL, Hemmelder MH, Jakulj L, van Kruijsdijk RCM, Kuypers DRJ, van der Meer P, van der Net JB, Nijmeijer HH, Vervloet MG, de Vries APJ, Walsh M, Wang AY, Gansevoort RT, Renal Lifecycle Trial Investigators (Ortiz A).
Nephrol Dial Transplant. 2025 Aug 29.40(9):1746-1755.
PMID: 40053493
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf046
External validation of the S-GRAS score for predicting recurrence in patients with adrenocortical carcinoma: implications for adjuvant mitotane therapy.
Jimenez-Fonseca P, Álvarez-Escola C, Ballester Navarro I, Hernando Cubero J, González Fernández L, Mangas Cruz MÁ, Iglesias C, García-Donas J, Picón MJ, Paja M, González Batanero L, García L, Molina J, Jimeno Maté R, Aller J, Romero MDCT, Cardenas Salas J, Gutiérrez-Buey G, Egaña Zunzunegui N, Navarro M, Lecumberri MJ, Valdés N, Carmona-Bayonas A.
Eur J Endocrinol. 2025 Jul 31.193(2):320-328.
PMID: 40810251
FI: 5,2
http://dx.doi.org/10.1093/ejendo/lvaf171
High Levels of Galectin-3 and Uric Acid Are Independent Predictors of Renal Impairment in Patients with Stable Coronary Artery Disease.
Leal-Pérez N, Blanco-Colio LM, Martín-Ventura JL, Gutiérrez-Landaluce C, Mahíllo-Fernández I, González-Casaus ML, Lorenzo Ó, Egido J, Tuñón J.
J Clin Med. 2025 Jul 25.14(15).
PMID: 40806886
FI: 2,9
http://dx.doi.org/10.3390/jcm14155264
Living and deceased donor kidney transplant rates across Europe: ERA Registry Figure of the month.
Stel VS, Ortiz A, Kramer A.
Clin Kidney J. 2025 Jul.18(7):sfaf236.
PMID: 40799934
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf236
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain.
Goi J, Paja Fano M, Rizo Gellida A, González-Boillos M, Rojas-Marcos PM, Caja Guayerbas L, García Cano AM, Ruiz-Sanchez JG, Vicente A, Gómez-Hoyos E, Recasens M, Barahona San Millan R, Picón César MJ, Díaz Guardiola P, Perdomo CM, Manjón-Miguélez L, Rebollo Román Á, Robles Lázaro C, Recio JM, Calatayud M, Jiménez López N, Sampedro Nuñez M, Ribas EM, Sanmartín Sánchez A, Diaz CG, Lamas C, Serrano J, Michalopoulou T, Rodrigo ST, Pascual-Corrales E, Aguila FJ, Muñoz Rivas N, Moya Mateo EM, Gutiérrez-Medina S, Hanzu FA, Parra Ramírez P, Araujo-Castro M.
Eur J Endocrinol. 2025 Jul 31.193(2):297-309.
PMID: 40743244
FI: 5,2
http://dx.doi.org/10.1093/ejendo/lvaf158
Myocardial Ischaemic Syndromes in Chronic Kidney Disease: Risky Pathways from Non-Acute to Acute Events.
Zoccali C, Chinnappa S, Fernández-Fernández B, Iatridi F, Mallamaci F, Mark PB, Ntounousi E, Piko N, Stegbauer J, Torino C, Valdivielso JM, Van Craenenbroeck A, Vogt L, De Caterina R.
Nephrol Dial Transplant. 2025 Jul 30.
PMID: 40736534
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf142
Clinical Effectiveness of Oral Semaglutide in Women with Type 2 Diabetes: A Nationwide, Multicentre, Retrospective, Observational Study (Women_ENDO2S-RWD Substudy).
Reyes-Garcia R, Moreno-Pérez O, Guillen-Morote C, Modrego-Pardo I, Doulatram-Gamgaram VK, Casado Cases C, Arias Mendoza N, Tejera-Pérez C, Cárdenas-Salas J, Martínez-Fuster S, Lardiés-Sánchez B, Márquez-Pardo R, Pinés P, Tejera-Muñoz A, Fernández-García JC, On Behalf Of The Seen Diabetes Area.
Nutrients. 2025 Jul 17.17(14).
PMID: 40732973
FI: 5
http://dx.doi.org/10.3390/nu17142349
Prevalence of reduced eGFR in European adults using KDIGO and age-adapted eGFR thresholds.
Astley ME, Chesnaye NC, Gambaro G, Ortiz A, Hallan S, Carrero JJ, Ebert N, Eriksen BO, Faucon AL, Ferraro PM, Ittermann T, Jonsson AJ, Langlo KAR, Melsom T, Schaeffner E, Stracke S, Palsson R, Jager KJ, Stel VS.
Nephrol Dial Transplant. 2025 Jul 17.
PMID: 40674065
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf112
Loop diuretics in anuric hemodialysis patients for the clearance of protein-bound uremic toxins.
Sánchez-Ospina D, Romero-Cote M, Criado-Bellido L, Saez-Calero MI, Hijazi-Prieto B, Delgado-Cuesta S, Herrera-Gómez F, Mujika-Marticorena M, Gonzalez-Parra E, Izquierdo-Ortiz MJ, Mas-Fontao S.
Clin Kidney J. 2025 Jul.18(7):sfaf195.
PMID: 40671697
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf195
Heterogeneity of regional and national hospitalization burden of lupus nephritis and systemic lupus erythematous.
Avello A, Fernández-Prado R, Abasheva D, Mahillo I, González-Gay MÁ, Martín-Cleary C, Arce-Obieta JM, Pérez-Gómez MV, Fernández-Fernández B, Ortiz A.
Clin Kidney J. 2025 Jul.18(7):sfaf162.
PMID: 40625697
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf162
Immunoglobulin A/PIGR axis as potential mediators of human abdominal aortic aneurysms revealed by topologically resolved proteomics.
Cerro-Pardo I, Núñez E, Picatoste B, Márquez-Gálvez C, Ortega-Villanueva L, Raposo-Gutiérrez I, Lindholt JS, Blanco-Colio LM, Ramiro AR, Vázquez J, Martín-Ventura JL.
J Transl Med. 2025 Jul 07.23(1):747.
PMID: 40624587
FI: 7,5
http://dx.doi.org/10.1186/s12967-025-06758-y
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.
Fernandez-Fernandez B, Sarafidis P, Ortiz A.
N Engl J Med. 2025 Jul 03.393(1):96-97.
PMID: 40601948
FI: 78,5
http://dx.doi.org/10.1056/NEJMc2506053
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Vaccine Coverage Collaborators(Ortiz A).
Lancet. 2025 Jul 19.406(10500):235-260.
PMID: 40578370
FI: 88,5
http://dx.doi.org/10.1016/S0140-6736(25)01037-2
A call for urgent action on chronic kidney disease across Europe.
Ferro CJ, Wanner C, Luyckx V, Fontana M, Gallego D, Vanholder R, Torra R, Ortiz A, Stronger Kidneys Taskforce of the European Renal Association, the European Kidney Health Alliance and the European Kidney Patients Federation.
Lancet Reg Health Eur. 2025 Jul.54:101347.
PMID: 40548327
FI: 13
http://dx.doi.org/10.1016/j.lanepe.2025.101347
Development of SOCS1 mimetics as novel approach to harmonize inflammation, oxidative stress, and fibrogenesis in metabolic dysfunction-associated steatotic liver disease.
Bernal S, Prieto I, Kavanagh M, Del Real IH, La Manna S, Lázaro I, Quiceno H, López-Sanz L, Picatoste B, Valdecantos MP, Mas-Fontao S, Sala-Vila A, Valverde ÁM, Marasco D, Egido J, Gómez-Guerrero C.
Redox Biol. 2025 Jul.84:103670.
PMID: 40373621
FI: 11,9
http://dx.doi.org/10.1016/j.redox.2025.103670
Adult prognosis of childhood kidney replacement therapy: ERA Registry Figure of the Month.
Stel VS, Ortiz A, Kramer A.
Clin Kidney J. 2025 Jun.18(6):sfaf204.
PMID: 40625691
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf204
Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial.
Saxena M, Laffin L, Borghi C, Fernandez Fernandez B, Ghali JK, Kopjar B, Polu K, Roger SD, Slingsby BT, Strutz F, Vogt L, Weir MR, Rodman D, Launch-HTN Investigators.
JAMA. 2025 Jun 30.
PMID: 40587141
FI: 55
http://dx.doi.org/10.1001/jama.2025.9413
The Role of miR-802 in Diabetic Kidney Disease: Diagnostic and Therapeutic Insights.
Tejera-Muñoz A, Marchant V, Tejedor-Santamaría L, Opazo-Ríos L, Lavoz C, Gimeno-Longas MJ, Aceña JL, Ruiz-Ortega M, Rodrigues-Díez RR.
Int J Mol Sci. 2025 Jun 07.26(12).
PMID: 40564936
FI: 4,9
http://dx.doi.org/10.3390/ijms26125474
Antioxidant Effects of SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic (CKM) Syndrome.
Guerrero-Mauvecin J, Villar-Gómez N, Miño-Izquierdo L, Povo-Retana A, Ramos AM, Ruiz-Hurtado G, Sanchez-Niño MD, Ortiz A, Sanz AB.
Antioxidants (Basel). 2025 Jun 09.14(6).
PMID: 40563333
FI: 6,6
http://dx.doi.org/10.3390/antiox14060701
Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Ortiz A, Arreola Guerra JM, Chan JCN, Jha V, Kramer H, Nicholas SB, Pavkov ME, Wanner C, Wong LP, Cheung M, King JM, Grams ME, Jadoul M, Tuttle KR, Conference Participants.
Kidney Int. 2025 Jun 18.
PMID: 40536455
FI: 12,6
http://dx.doi.org/10.1016/j.kint.2025.04.005
Trends and Risk Factors of Pediatric Venous Thromboembolism in Spain: A Nationwide Study from 2016 to 2023.
Rueda-Camino JA, Sabrido-Bermúdez G, Barba-Martín R.
J Clin Med. 2025 Jun 03.14(11).
PMID: 40507718
FI: 2,9
http://dx.doi.org/10.3390/jcm14113950
Chronic Kidney Disease of unexplained cause (CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA.
Halbritter J, Figueres L, Van Eerde AM, Capasso G, Hoorn EJ, Nijenhuis T, Perez-Gomez MV, Sayer JA, Simons M, Walsh S, Zagorec N, Müller RU, Cornec-Le Gall E.
Nephrol Dial Transplant. 2025 Jun 03.
PMID: 40459916
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf092
Towards early diagnosis of amyotrophic lateral sclerosis using near fibre EMG.
Garnés-Camarena O, Mahíllo-Fernández I, Martínez-Ulloa P, Mandeville R, Lorenzo O, Stashuk DW.
Clin Neurophysiol. 2025 Jun.174:114-122.
PMID: 40267619
FI: 3,6
http://dx.doi.org/10.1016/j.clinph.2025.04.006
Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study.
Lee S, Son Y, Hwang J, Kim MS, GBD 2021 Dietary Iron Deficiency Collaborators, Il Shin J, Yon DK, Kassebaum NJ (Ortiz A).
Nat Med. 2025 Jun.31(6):1809-1829.
PMID: 40263631
FI: 50
http://dx.doi.org/10.1038/s41591-025-03624-8
Ultra-processed foods and cardio-kidney-metabolic syndrome: A review of recent evidence.
Kanbay M, Ozbek L, Guldan M, Abdel-Rahman SM, Narin AE, Ortiz A.
Eur J Intern Med. 2025 Jun.136:4-18.
PMID: 40122730
FI: 6,1
http://dx.doi.org/10.1016/j.ejim.2025.03.017
Age- and sex-specific reference values of estimated glomerular filtration rate for European adults.
Astley ME, Chesnaye NC, Hallan S, Gambaro G, Ortiz A, Carrero JJ, Ebert N, Eriksen BO, Faucon AL, Ferraro PM, Indridason OS, Ittermann T, Jonsson AJ, Rise Langlo KA, Melsom T, Schaeffner E, Stracke S, Stel VS, Jager KJ.
Kidney Int. 2025 Jun.107(6):1076-1087.
PMID: 40122341
FI: 12,6
http://dx.doi.org/10.1016/j.kint.2025.02.025
Dasatinib and Quercetin Combination Increased Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy.
Battaglia-Vieni A, Marchant V, Tejedor-Santamaria L, García-Caballero C, Flores-Salguero E, Ruiz-Torres MP, Rayego-Mateos S, Sanz AB, Ortiz A, Ruiz-Ortega M.
Pharmaceuticals (Basel). 2025 May 30.18(6).
PMID: 40573218
FI: 4,8
http://dx.doi.org/10.3390/ph18060822
Nursing Students' Perceptions of Clinical Debriefing TALK©: A Qualitative Case Study.
González-Tejerina B, Pérez-Corrales J, Palacios-Ceña D, Abad-Valle J, Gómez PR, González-Toledo B, García-Carpintero Blas E, Garrigues-Ramón M.
Nurs Rep. 2025 May 30.15(6).
PMID: 40559485
FI: 2
http://dx.doi.org/10.3390/nursrep15060194
A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study.
Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, Garcia-Osuna R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S, Coloma A, Roberto Robles N, Agraz I, Poch E, Rodas L, Lozano V, Fernández-Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García-Fernández N, Goicoechea M, Calero F, Bonet J, Liaño F, Pascual J, Praga M, Fulladosa X, Soler MJ.
Nefrologia (Engl Ed). 2025 May.45(5):360-368.
PMID: 40518653
FI: 2,6
http://dx.doi.org/10.1016/j.nefroe.2025.04.004
Phthalate Metabolites and Their Relationship with Abdominal and General Obesity: Evidence from the Aragon Workers' Health Study (AWHS).
Akritidis J, Mérida DM, Torrijo-Belanche C, Moreno-Franco B, Gimeno-Ruiz S, Rey-García J, Morales-Suarez-Varela M, Guallar-Castillón P.
Nutrients. 2025 May 30.17(11).
PMID: 40507138
FI: 5
http://dx.doi.org/10.3390/nu17111869
Defective Mitochondrial Respiration in Hereditary Thoracic Aneurysms.
Marcos-Ríos D, Rochano-Ortiz A, Méndez-Barbero N, Oller J.
Cells. 2025 May 23.14(11).
PMID: 40497944
FI: 5,2
http://dx.doi.org/10.3390/cells14110768
Inherited kidney disease and CAKUT are common causes of kidney failure: ERA Registry Figure of the month.
Stel VS, Ortiz A, Kramer A.
Clin Kidney J. 2025 May.18(5):sfaf163.
PMID: 40453546
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf163
Improvement in the detection, diagnosis, and early treatment of chronic kidney disease in Spain. The IntERKit project.
Górriz JL, Adán Gil F, Botana López MA, Buño Soto A, Campos Cabrera FJ, Cisneros A, Cobo Guerrero S, Conejos MD, Egocheaga Cabello I, Fernández Planelles MC, García-Matarín L, Jiménez N, Julián Mauro JC, León Jiménez D, Martínez Gamote D, Mazón Ramos P, Ortiz A, Palau G, Quevedo Rivera J, Sánchez-Álvarez JE, Tristancho Ajamil R, Varga Martín C, Vallés Fernández R.
Nefrologia (Engl Ed). 2025 May.45(5):351-359.
PMID: 40436675
FI: 2,6
http://dx.doi.org/10.1016/j.nefroe.2025.05.001
Impact of albuminuria screening in primary care on the detection and management of chronic kidney disease: findings from the ONDAAS study.
Sánchez-Ospina D, Mas-Fontao S, Palencia MM, Prieto BH, Sánchez CG, Carcedo SP, Albo MR, Egido J, Ortiz A, Gonzalez-Parra E, Izquierdo Ortiz MJ, ONDAAS study investigators .
Clin Kidney J. 2025 May.18(5):sfaf123.
PMID: 40416393
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf123
Prognostic value of extreme NT-proBNP levels in patients hospitalized for heart failure.
Yebra Yebra M, Sáenz de Urturi Rodríguez A, González García S, de Peralta García P, Asenjo Martínez M, Rueda Camino JA, Barba Martín R.
Med Clin (Barc). 2025 May 22.165(1):106990.
PMID: 40409228
FI: 2,1
http://dx.doi.org/10.1016/j.medcli.2025.106990
siRNA-based therapeutics for lipoprotein (a) lowering: A path toward precision cardiovascular medicine.
Kanbay M, Ozbek L, Guldan M, Yilmaz ZY, Ortiz A, Mallamaci F, Zoccali C.
Eur J Clin Invest. 2025 May 23:e70079.
PMID: 40407123
FI: 3,6
http://dx.doi.org/10.1111/eci.70079
Klotho plasma levels are an independent predictorof mortality in women with acute coronary syndrome.
Cortés M, Kallmeyer A, Tarín N, Cristóbal C, Pello AM, Aceña A, Gutiérrez-Landaluce C, Huelmos A, Alonso J, López-Bescós L, Mahíllo-Fernández I, Lorenzo Ó, González-Casaus ML, Egido J, Tuñón J.
Sci Rep. 2025 May 14.15(1):16744.
PMID: 40369094
FI: 3,9
http://dx.doi.org/10.1038/s41598-025-01334-2
CCN2 Activates Cellular Senescence Leading to Kidney Fibrosis in Folic Acid-Induced Experimental Nephropathy.
Tejedor-Santamaria L, Marquez-Exposito L, Villacampa A, Marchant V, Battaglia-Vieni A, Rayego-Mateos S, Rodrigues-Diez RR, Santos FM, Valentijn FA, Knoppert SN, Broekhuizen R, Ruiz-Torres MP, Goldschmeding R, Ortiz A, Peiró C, Nguyen TQ, Ramos AM, Ruiz-Ortega M.
Int J Mol Sci. 2025 May 06.26(9).
PMID: 40362638
FI: 4,9
http://dx.doi.org/10.3390/ijms26094401
Targeting IL-6 in antibody-mediated kidney transplant rejection.
Kanbay M, Mizrak B, Copur S, Alper EN, Akgul S, Ortiz A, Susal C.
Clin Kidney J. 2025 May.18(5):sfaf108.
PMID: 40357502
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf108
Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019.
GBD 2019 Acute and Chronic Care Collaborators(Ortiz A).
Nat Commun. 2025 May 07.16(1):4235.
PMID: 40335470
FI: 15,7
http://dx.doi.org/10.1038/s41467-025-56910-x
Dietary vitamin D intake and 2-year changes in cognitive function in older adults with overweight or obesity and metabolic syndrome.
Vázquez-Lorente H, Ni J, Paz-Graniel I, Toledo E, Corella D, Castañer O, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem L, Bouzalmate-Hajjaj A, Tur JA, Pérez RMM, Fanlo M, Delgado-Rodríguez M, Bustelo AB, Vidal J, Vázquez C, Daimiel L, Ros E, Fernández-Aranda F, Rognoni T, Babio N, Asensio EM, Pérez-Vega KA, Garcia-Rios A, Compañ-Gabucio L, Cueto-Galán R, Zulet MA, Nafria M, Casas R, Cano-Ibáñez N, Tojal-Sierra L, Gómez-Pérez AM, Goñi N, Sorli JV, Zomeño MD, Arenas-Larriva AP, Jiménez-Sellés P, Basterra-Gortari J, Fitó M, Salas-Salvadó J.
Geroscience. 2025 May 06.
PMID: 40325312
FI: 5,4
http://dx.doi.org/10.1007/s11357-025-01670-1
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes.
Schnell O, Almandoz J, Anderson L, Barnard-Kelly K, Battelino T, Blüher M, Busetto L, Catrinou D, Ceriello A, Cos X, Danne T, Dayan CM, Del Prato S, Fernández-Fernández B, Fioretto P, Forst T, Gavin JR, Giorgino F, Groop PH, Harsch IA, Heerspink HJL, Heinemann L, Ibrahim M, Jadoul M, Jarvis S, Ji L, Kanumilli N, Kosiborod M, Landmesser U, Macieira S, Mankovsky B, Marx N, Mathieu C, McGowan B, Milenkovic T, Moser O, Müller-Wieland D, Papanas N, Patel DC, Pfeiffer AFH, Rahelić D, Rodbard HW, Rydén L, Schaeffner E, Spearman CW, Stirban A, Tacke F, Topsever P, Van Gaal L, Standl E.
Cardiovasc Diabetol. 2025 May 02.24(1):187.
PMID: 40316962
FI: 10,6
http://dx.doi.org/10.1186/s12933-025-02700-0
Inkjet-Printed Graphene Multielectrode Arrays: An Accessible Platform for In Vitro Cardiac Electrophysiology.
Lumpuy-Castillo J, Fu Y, Avila Ramirez AE, Solodka K, Li J, Lorenzo O, Zeglio E, Garma LD.
ACS Appl Bio Mater. 2025 May 19.8(5):3708-3716.
PMID: 40285727
FI: 4,7
http://dx.doi.org/10.1021/acsabm.4c01677
Increasing incidence of hypertensive disorders of pregnancy and association with decreased GFR and albuminuria: The need for post-partum follow-up.
Gracia-Iguacel C, Torán MP, Navidad MA, Pérez BG, Arce-Obieta JM, Morocho-Pindo C, González-Parra E, Mahillo I, Ortiz A.
Placenta. 2025 May 23.165:42-49.
PMID: 40203467
FI: 2,5
http://dx.doi.org/10.1016/j.placenta.2025.03.017
A salty symphony: unraveling the tale of uromodulin and sodium sensitivity.
Karagiannidis AG, Theodorakopoulou MP, Iatridi F, Ortiz A, Sarafidis P.
J Hum Hypertens. 2025 May.39(5):320-333.
PMID: 40164702
FI: 3,4
http://dx.doi.org/10.1038/s41371-025-01013-9
Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction.
Briones AM, Hernanz R, García-Redondo AB, Rodríguez C, Blanco-Colio LM, Val-Blasco A, Alonso MJ, Salaices M.
Basic Clin Pharmacol Toxicol. 2025 May.136(5):e70026.
PMID: 40159875
FI: 3,3
http://dx.doi.org/10.1111/bcpt.70026
Aging-related hyperphosphatemia triggers the release of TNF-α from macrophages, promoting indicators of sarcopenia through the reduction of IL-15 expression in skeletal muscle.
Alcalde-Estévez E, Moreno-Piedra A, Asenjo-Bueno A, Martos-Elvira M, de la Serna-Soto M, Ruiz-Ortega M, Olmos G, López-Ongil S, Ruiz-Torres MP.
Life Sci. 2025 May 01.368:123507.
PMID: 40010633
FI: 5,1
http://dx.doi.org/10.1016/j.lfs.2025.123507
Novel Truncating Variants in PODXL Represent a New Entity to Be Explored Among Podocytopathies.
García-Aznar JM, Besada-Cerecedo ML, Castro-Alonso C, Sierra Carpio M, Blasco M, Quiroga B, Červienka M, Mouzo R, Torra R, Ortiz A, de Sequera P.
Genes (Basel). 2025 Apr 18.16(4).
PMID: 40282423
FI: 2,8
http://dx.doi.org/10.3390/genes16040464
Drivers and mechanisms of cognitive decline in chronic kidney disease.
Capasso G, Franssen CFM, Perna AF, Massy ZA, Menzies RI, Zoccali C, Tessitore A, Nedergaard M, Okusa MD, Ortiz A, Wagner CA, Unwin RJ.
Nat Rev Nephrol. 2025 Apr 25.
PMID: 40281076
FI: 39,8
http://dx.doi.org/10.1038/s41581-025-00963-0
Mitochondrial Dysfunction: A New Hallmark in Hereditable Thoracic Aortic Aneurysm Development.
Marcos-Ríos D, Rochano-Ortiz A, San Sebastián-Jaraba I, Fernández-Gómez MJ, Méndez-Barbero N, Oller J.
Cells. 2025 Apr 21.14(8).
PMID: 40277943
FI: 5,2
http://dx.doi.org/10.3390/cells14080618
ERA Registry Figure of the month Expected remaining years of life for dialysis and kidney transplant patients.
Stel VS, Ortiz A, Kramer A.
Clin Kidney J. 2025 Apr.18(4):sfaf091.
PMID: 40270644
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf091
Impact of primary aldosteronism on calcium phosphate homeostasis. Results from the SPAIN-ALDO.
Iriarte-Durán MB, Paja Fano M, Rizo Gellida A, González-Boillos M, Parra Ramírez P, Martín Rojas-Marcos P, Caja L, García Cano AM, Ruiz-Sanchez JG, Vicente A, Gómez-Hoyos E, Recasens M, Barahona San Millan R, Picón César MJ, Díaz Guardiola P, Perdomo CM, Manjón-Miguélez L, Rebollo Román Á, Robles Lázaro C, Recio JM, Calatayud M, Jiménez López N, Sampedro Nuñez M, Mena Ribas E, Sanmartín Sánchez A, Gonzalvo Diaz C, Lamas C, Serrano J, Michalopoulou T, Tenes Rodrigo S, Jaén Aguila F, Moya Mateo EM, Gutiérrez-Medina S, Hanzu FA, Araujo-Castro M.
J Endocrinol Invest. 2025 Apr 19.
PMID: 40252188
FI: 3,5
http://dx.doi.org/10.1007/s40618-025-02563-y
Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology.
Montero N, Oliveras L, Martínez-Castelao A, Gorriz JL, Soler MJ, Fernández-Fernández B, Quero M, García-Carro C, Garcia-Sancho P, Goicoechea M, Gorgojo Martínez JJ, Molina P, Puchades MJ, Rodríguez-Espinosa D, Sablón N, Santamaría R, Navarro-González JF, GEENDIAB (Spanish Diabetic Nephropathy Study Group).
Nefrologia (Engl Ed). 2025 Apr.45 Suppl 1:1-26.
PMID: 40222774
FI: 2,6
http://dx.doi.org/10.1016/j.nefroe.2025.04.005
Maintaining kidney health in aging societies: a JSN and ERA call to action.
Ortiz A, Kramer A, Rychlík I, Nangaku M, Yanagita M, Jager KJ, Caskey FJ, Stel VS, Kashihara N, Kuragano T, Suzuki Y, Takemoto Y, Yokoi H, Palladino G, Fliser D, Torra R, Wanner C.
Nephrol Dial Transplant. 2025 Apr 10.
PMID: 40210592
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf068
Transgender women and competitive sports: Considerations from Endocrinology.
Cuadrado Clemente L, Miguélez González M, Cabrera García P, Noval Font M, Alfaro Gandarillas É, Gómez Balaguer M, Palacios Gil de Antuñano N.
Endocrinol Diabetes Nutr (Engl Ed). 2025 Apr.72(4):101539.
PMID: 40185657
FI: 1,8
http://dx.doi.org/10.1016/j.endien.2025.101539
Spanish Registry of Renal Patients: 2022 Report and evolutive analysis.
Quiroga B, Mahíllo B, Mazuecos A, Ortiz A, Farnés JC, Marrero DH, Alemán ST, de Pablos MCS, Arévalo OLR, Vidas MM, Slon-Roblero MF, Larrañaga MA, Eguren IM, Muñoz MOV, Camblor MR, Alia IM, Caamaño MEB, Galán MAB, Lorenzo JD, López HG, Monzon FEA, Marqués GG, Rodríguez-Benot A, Domínguez-Gil B, Álvarez ES, en nombre de todos los representantes del REER.
Nefrologia (Engl Ed). 2025 Apr.45(4):312-328.
PMID: 40175214
FI: 2,6
http://dx.doi.org/10.1016/j.nefroe.2025.03.002
ERA Registry Figure of the month Trends in kidney transplantation rate across countries.
Stel VS, Ortiz A, Kramer A.
Clin Kidney J. 2025 Mar.18(3):sfaf055.
PMID: 40123965
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf055
ABCDE to identify and prevent chronic kidney disease: a call to action.
Ferro CJ, Wanner C, Luyckx V, Stevens K, Cerqueira S, Darwish R, Fernandez Fernandez B, Fiel D, Filev R, Grieger M, Lopez A, Luman M, Malyszko J, Nikolova-Vlahova MK, Romero F, Skalioti C, Araújo CARDS, Ziedina I, Gallego D, Ortiz A, Torra R, Vanholder R.
Nephrol Dial Transplant. 2025 Mar 19.
PMID: 40107862
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf057
Predictive factors of gait recovery after hip fracture: a scoping review.
González de Villaumbrosia C, Barba R, Ojeda-Thies C, Grifol-Clar E, Álvarez-Diaz N, Álvarez-Espejo T, Cancio-Trujillo JM, Mora-Fernández J, Pareja-Sierra T, Barrera-Crispín R, Calle-Egusquiza A, Capdevila-Reniu A, Carrasco-Paniagua C, Cervera Díaz MC, Condorhuamán-Alvarado P, Cotano-Abad L, Cuadra-Llopart L, García-Cárdenas V, González-Chávez S, Hernández-Sánchez LA, Herrero-Pinilla B, López-Castro J, Montero-Fernández N, Muñoz-Pascual A, Muñoz-Vélez M, Ortés-Gómez R, Sáenz-Tejada A, Sanz-Reig J, Torras-Cortada S, Ramos Cortés M, Sáez-López P.
Age Ageing. 2025 Mar 03.54(3).
PMID: 40100147
FI: 7,1
http://dx.doi.org/10.1093/ageing/afaf057
Oxidative stress and inflammation on metabolic abnormalities and renal involvement in prediabetic subjects across Europe.
Mas-Fontao S, Civantos E, Boukichou-Abdelkader N, Soto-Catalan M, Romeo-Colas M, Marco A, Gomez-Guerrero C, Moreno JA, Tuomilehto J, Gabriel R, Egido J, ePREDICE investigators.
Nefrologia (Engl Ed). 2025 Mar.45(3):238-248.
PMID: 40082053
FI: 2,6
http://dx.doi.org/10.1016/j.nefroe.2025.02.009
Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors.
Andrade A, Bachmann M, Bobot M, Bruchfeld A, Fridolin I, Mani LY, Xu H, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators (Ortiz A).
Nephrol Dial Transplant. 2025 Mar 13.40(Supplement_2):ii18-ii27.
PMID: 40080092
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfae256
The role of the intestinal microbiome in cognitive decline in patients with kidney disease.
Wagner CA, Frey-Wagner I, Ortiz A, Unwin R, Liabeuf S, Suzumoto Y, Iervolino A, Stasi A, Di Marzo V, Gesualdo L, Massy ZA, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators.
Nephrol Dial Transplant. 2025 Mar 13.40(Supplement_2):ii4-ii17.
PMID: 40080091
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfae253
Cognitive impairment in kidney transplanted patients.
Malyszko J, Golenia A, Farisco M, Re VL, Klimkowicz-Mrowiec A, Capasso G, Goumenos D, Rroji M, Figurek A, Hafez G, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators (Ortiz A).
Nephrol Dial Transplant. 2025 Mar 13.40(Supplement_2):ii46-ii53.
PMID: 40080090
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfae250
Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia.
Zoccali C, Mallamaci F, Rosenberg K, Unwin R, Silva PI, Simeoni MA, Hafez G, Capasso G, Nitsch D, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators (Ortiz A).
Nephrol Dial Transplant. 2025 Mar 13.40(Supplement_2):ii37-ii45.
PMID: 40080089
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfae255
Chemotherapy-related cognitive impairment and kidney dysfunction.
Simeoni M, Mulholland MM, Workeneh BT, Capasso A, Hafez G, Liabeuf S, Malyszko J, Mani LY, Trevisani F, De A, Wagner CA, Massy ZA, Unwin R, Capasso G, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators (Ortiz A).
Nephrol Dial Transplant. 2025 Mar 13.40(Supplement_2):ii54-ii63.
PMID: 40080088
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfae249
CONNECT: what has been done and what needs to be done.
Capasso G, Unwin RJ, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators (Ortiz A).
Nephrol Dial Transplant. 2025 Mar 13.40(Supplement_2):ii1-ii3.
PMID: 40080087
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfae248
Care pathways for patients with cognitive impairment and chronic kidney disease.
Pépin M, Giannakou K, Levassort H, Farinha A, Bobot M, Lo Re V, Golenia A, Małyszko J, Mattace-Raso F, Klimkowcz-Mrowiec A, Garneata L, Vazelov E, Stepan E, Capolongo G, Massy Z, Wiecek A, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators (Ortiz A).
Nephrol Dial Transplant. 2025 Mar 13.40(Supplement_2):ii28-ii36.
PMID: 40080086
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfae264
Genetic and circulating biomarkers of cognitive dysfunction and dementia in CKD.
Zoccali C, Mallamaci F, Wagner CA, Unwin R, Nedergaard M, Hafez G, Malyszko J, Pepin M, Massy Z, Paolisso G, Remuzzi G, Capasso GB, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators (Ortiz A).
Nephrol Dial Transplant. 2025 Mar 13.40(Supplement_2):ii64-ii75.
PMID: 40080085
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfae259
Very low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events.
Fernandez-Fernandez B, Valdivielso JM, Chinnappa S, Sarafidis P, Ortiz A.
Nephrol Dial Transplant. 2025 Mar 07.
PMID: 40053494
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf053
Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
GBD 2021 Adult BMI Collaborators(Ortiz A).
Lancet. 2025 Mar 08.405(10481):813-838.
PMID: 40049186
FI: 88,5
http://dx.doi.org/10.1016/S0140-6736(25)00355-1
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
GBD 2021 Adolescent BMI Collaborators (Ortiz A).
Lancet. 2025 Mar 08.405(10481):785-812.
PMID: 40049185
FI: 88,5
http://dx.doi.org/10.1016/S0140-6736(25)00397-6
Recommendations of the Spanish Society of Endocrinology and Nutrition (SEEN) on ""what not to do"" in clinical practice.
Díez JJ, Anda E, Bretón I, González-Blanco C, Miguélez M, Zugasti A, Fernández A, Sociedad Española de Endocrinología y Nutrición.
Endocrinol Diabetes Nutr (Engl Ed). 2025 Mar.72(3):101531.
PMID: 40037943
FI: 1,8
http://dx.doi.org/10.1016/j.endien.2025.101531
Towards a reduction of patients' refusal to perform arteriovenous fistula: New tools and new actors in the interdisciplinary vascular access team. Presentation of the ERCAV project.
Rosique López F, Luz Sánchez-Tocino M, Hernán Gascueña D, Santos-Ascarza Bacariza JL, Andúgar Rocamora L, Gallego Zurro D, Cabezuelo Romero JB, Prieto Velasco M, Martínez Losa A, Hadad-Arrascue F, Martínez Alarcón L, Manzano Sánchez D, Melero Rubio E, López Picasso M, Hernández A, Rubio Paez S, Roca-Tey R, Ibeas López J, Dolores Arenas M, Grupo de Trabajo Fundación Renal Grupo EspañolMutildisciplinar del Acceso Vascular (GEMAV), GTAVSEN (Grupo de Trabajo del AccesoVascular de la S.E.N.), Grupo de Trabajo de ERCA (Grupo de Trabajo de EnfermedadRenal Crónica Avanzada), Federación ALCER (Federación Nacional de Asociaciones parala lucha contra las enfermedades del riñón).
Nefrologia (Engl Ed). 2025 Mar.45(3):189-193.
PMID: 39986980
FI: 2,6
http://dx.doi.org/10.1016/j.nefroe.2025.02.006
Diabetic foot infections in Internal Medicine services in Spain (2018-2022).
Fuentes Santos C, Rueda Camino JA, Asenjo Mota Á, Castaneda Pastor A, Zapatero Gaviria A, Canora Lebrato J, Barba-Martín R.
Rev Clin Esp (Barc). 2025 Mar.225(3):125-130.
PMID: 39864519
FI: 1,7
http://dx.doi.org/10.1016/j.rceng.2025.01.006
Cognitive impairment in CKD patients: a guidance document by the CONNECT network.
Bolignano D, Simeoni M, Hafez G, Pepin M, Gallo A, Altieri M, Liabeuf S, Giannakou K, De A, Capasso G, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators (Ortiz A).
Clin Kidney J. 2025 Feb.18(2):sfae294.
PMID: 40235626
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfae294
ERA Registry Figure of the month Patient survival on dialysis and kidney transplantation.
Stel VS, Ortiz A, Kramer A.
Clin Kidney J. 2025 Feb.18(2):sfaf051.
PMID: 40040958
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf051
Kidney expert consultation and the outcomes of in hospital acute kidney injury.
Saritas T, Cantaluppi V, Sanz Bartolome A, Faguer S, Gameiro J, Antonio Lopes J, Malyszko J, Ostermann M, Selby NM, De Seigneux S.
Nephrol Dial Transplant. 2025 Feb 28.
PMID: 40036875
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf043
The ERA Registry Annual Report 2022: Epidemiology of Kidney Replacement Therapy in Europe, with a focus on sex comparisons.
Boenink R, Bonthuis M, Boerstra BA, Astley ME, Montez de Sousa IR, Helve J, Komissarov KS, Comas J, Radunovic D, Buchwinkler L, Hommel K, Gjorgjievski N, Galvão AA, Mitsides N, Vidas MM, Dębska-Ślizień AM, Ambrus C, Slon-Roblero MF, Ten Dam MAGJ, Lassalle M, Guidotti R, Marín Sánchez I, Kuzema V, Trujillo Alemán S, Ziginskiene E, Santhakumaran S, Valentin MO, Sarrión Auñón A, Indridason OS, Seyahi N, Artamendi Larrañaga M, Kravljaca M, Okša A, García López H, Åsberg A, Rychlik I, Ots-Rosenberg M, Beckerman P, Godanci-Kelmendi V, Stendahl M, Lakey J, Jager KJ, Ortiz A, Kramer A, Stel VS.
Clin Kidney J. 2025 Feb.18(2):sfae405.
PMID: 40008269
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfae405
Psychobiotic Protection of Nutritional Supplements and Probiotics in Patients Undergoing Hemodialysis: A Randomized Trial.
Climent E, Hevilla F, Padial M, Barril-Cuadrado G, Blanca M, Jiménez-Salcedo T, López-Picasso M, Nogueira-Pérez Á, Olveira G.
Nutrients. 2025 Feb 12.17(4).
PMID: 40004979
FI: 5
http://dx.doi.org/10.3390/nu17040652
Quality of life and clinical data in hemodialysis patients with different degrees of pruritus.
Fontao SM, Manso P, Audije-Gil J, Gascueña DH, Dapena F, Aresté N, Sánchez-Álvarez E, Molina P, Ojeda R, Goicoechea M, Simó VE, Bezhold GA, Prieto-Velasco M, Lloret MJ, Santos AB, Buades JM, Narváez C, Sánchez-Villanueva R, Pérez-Morales RE, Jiménez MDA, Fundación Renal Española Working Group, Prurito Working Group.
Sci Rep. 2025 Feb 20.15(1):6222.
PMID: 39979317
FI: 3,9
http://dx.doi.org/10.1038/s41598-024-83833-2
Pasta Consumption and Cardiometabolic Risks in Older Adults with Overweight/Obesity: A Longitudinal Analysis.
Shyam S, Nishi SK, Ni J, Martínez-González MÁ, Corella D, Schröder H, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem L, Bueno-Cavanillas A, Tur JA, Martín Sánchez V, Pintó X, Delgado-Rodríguez M, Matía-Martín P, Vidal J, Vázquez C, Daimiel L, Ros E, Gaforio JJ, Ruiz-Canela M, Fernández-Carrión R, Goday A, Garcia-Rios A, Torres-Collado L, Cueto-Galán R, Zulet MA, Prohens L, Casas R, Castillo-Hermoso MA, Tojal-Sierra L, Am GP, García-Arellano A, Sorlí JV, Castañer O, Arenas-Larriva AP, Oncina-Cánovas A, Goñi L, Fitó M, Babio N, Salas-Salvadó J.
J Am Nutr Assoc. 2025 Feb 19:1-13.
PMID: 39970054
FI: 2,6
http://dx.doi.org/10.1080/27697061.2025.2463454
Access to kidney transplantation and re-transplantation from childhood to adulthood: long-term data from the ERA Registry.
Preka E, Bonthuis M, Marks SD, Kramer A, de Vries APJ, Sørensen SS, Bakkaloğlu SA, Bistrup C, Jahnukainen T, Arévalo OLR, Buchwinkler L, Segelmark M, Sanchez JE, Arnol M, Ordóñez-Álvarez FA, de la Cerda-Ojeda F, Plumb LA, Methven S, Palsson R, Lundgren T, Ríos H, Ortiz A, Stel VS, Harambat J, Jager KJ.
Nephrol Dial Transplant. 2025 Feb 12.
PMID: 39938931
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf025
Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society.
Pedro-Botet J, Arrieta F, Botana M, Gimeno-Orna JA, Martínez-Montoro JI, Ortega-Martínez de Victoria E, Ribalta J, Sánchez-Margalet V, Pérez-Pérez A, Grupo de Trabajo de Enfermedad Cardiovascular de la Sociedad Española de Diabetes.
Endocrinol Diabetes Nutr (Engl Ed). 2025 Feb.72(2):101523.
PMID: 39924389
FI: 1,8
http://dx.doi.org/10.1016/j.endien.2025.101523
Insights into the mechanisms of fibrosis and progressive kidney injury.
Lamas S, Ruiz-Ortega M.
Nat Rev Nephrol. 2025 Feb.21(2):79-80.
PMID: 39753691
FI: 39,8
http://dx.doi.org/10.1038/s41581-024-00922-1
New Biomarkers in the Prognostic Assessment of Acute Heart Failure with Reduced Ejection Fraction: Beyond Natriuretic Peptides.
Cortés M, Lumpuy-Castillo J, García-Talavera CS, Arroyo Rivera MB, de Miguel L, Bollas AJ, Romero-Otero JM, Esteban Chapel JA, Taibo-Urquía M, Pello AM, González-Casaus ML, Mahíllo-Fernández I, Lorenzo O, Tuñón J.
Int J Mol Sci. 2025 Jan 24.26(3).
PMID: 39940753
FI: 4,9
http://dx.doi.org/10.3390/ijms26030986
ERA Registry Figure of the month Time trends in dialysis incidence across age groups and countries.
Stel VS, Ortiz A, Kramer A.
Clin Kidney J. 2025 Jan.18(1):sfaf013.
PMID: 39896976
FI: 4,6
http://dx.doi.org/10.1093/ckj/sfaf013
Cardiovascular risk assessment: Missing albuminuria contributing to gender inequality.
de Sequera P, Arias J, Quiroga B, Benavent M, Procaccini F, Romero I, López G, Diez J, Ortiz A.
Nefrologia (Engl Ed). 2025 Jan.45(1):87-93.
PMID: 39884803
FI: 2,6
http://dx.doi.org/10.1016/j.nefroe.2025.01.002
Plasmid Gene Therapy for Monogenic Disorders: Challenges and Perspectives.
Luís MA, Goes MAD, Santos FM, Mesquita J, Tavares-Ratado P, Tomaz CT.
Pharmaceutics. 2025 Jan 14.17(1).
PMID: 39861752
FI: 5,5
http://dx.doi.org/10.3390/pharmaceutics17010104
Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A consensus statement of the ERA Genes & Kidney Working Group.
Geertsema P, Gansevoort RT, Arici M, Capasso G, Cornec-Le-Gall E, Furlano M, Fuster DG, Galletti F, Gómez-Dos-Santos V, Perez-Gomez MV, Goumenos D, Halbritter J, Jambon E, Korst U, Leliveld AM, Felip MM, Figueiredo A, Nijenhuis T, Olsburgh J, Pol RA, Sayer JA, Stippel D, Torra R, Müller RU, Casteleijn NF, members of the study group.
Nephrol Dial Transplant. 2025 Jan 23.
PMID: 39848914
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf019
Annexin A8 deficiency delays atherosclerosis progression.
Gutiérrez-Muñoz C, Blázquez-Serra R, San Sebastian-Jaraba I, Sanz-Andrea S, Fernández-Gómez MJ, Nuñez-Moreno G, Mínguez P, Escolá-Gil JC, Nogales P, Ollivier V, Martín-Ventura JL, Ho-Tin-Noe B, Rescher U, Méndez-Barbero N, Blanco-Colio LM.
Clin Transl Med. 2025 Jan.15(1):e70176.
PMID: 39835780
FI: 6,8
http://dx.doi.org/10.1002/ctm2.70176
DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction -Implications for clinicians.
Malyszko J, De Seigneux S, Cantaluppi V, Faguer S, Gameiro J, Lopes JA, Sanz Bartolome A, Saritas T, Selby NM, Ostermann M.
Nephrol Dial Transplant. 2025 Jan 15.
PMID: 39814582
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf013
Stratified medicine for blood pressure targets in type 2 diabetes mellitus.
Fernandez-Fernandez B, Valdivielso JM, Vogt L, Sarafidis P, Ortiz A.
Nephrol Dial Transplant. 2025 Jan 13.
PMID: 39805717
FI: 5,6
http://dx.doi.org/10.1093/ndt/gfaf007
Trained immunity: from kidney failure to organ transplantation.
Ochando J, Ortiz A.
Nat Rev Nephrol. 2025 Jan 06.
PMID: 39762368
FI: 39,8
Projects, contracts and observational studies
PUBLIC
Sources of public funding for projects being developed at the IIS-FJD:

|
REFERENCE |
PROJECT TITLE |
PRINCIPAL RESEARCHER |
TYPE OF PROJECT |
TOTAL FUNDING |
|
CA21165 |
PERSONALIZED MEDICINE IN CHRONIC KIDNEY DISEASE: IMPROVED OUTCOME BASED ON BIG DATA (PERMEDIK) |
AVELLO ESCRIBANO, ALEJANDRO |
COLLABORATION NETWORKS. INTERNATIONAL |
€0.00 |
|
AC22/00028 |
BODY FLUID PROTEOME SIGNATURES FOR PERSONALISED INTERVENTION TO PREVENT CARDIOVASCULAR AND RENAL COMPLICATIONS IN DIABETES |
FERNANDEZ FERNANDEZ, BEATRIZ |
CLINICAL RESEARCH PROJECTS. INTERNATIONAL |
€148,830.00 |
|
AC22/00027 |
MULTI-MARKERS RISK ASSESSMENT OF KIDNEY SENSITIVITY TO INJURY TO PERSONALIZE PREVENTION OF ACUTE KIDNEY INJURY |
ORTIZ ARDUAN, ALBERTO |
CLINICAL RESEARCH PROJECTS. INTERNATIONAL |
€173,030.00 |
|
KITNEWCARE (101137054) |
KITNEWCARE. DEVELOPING A FRAMEWORK/MODEL TO ENVIRONMENTALLY SUSTAINABLE AND CLIMATE NEUTRAL HEALTH AND CARE SYSTEMS USING THE KIDNEY CARE PATHWAY |
ORTIZ ARDUAN, ALBERTO |
CLINICAL RESEARCH PROJECTS. INTERNATIONAL |
€372,778.75 |
|
PREVENTCKD (101101220) |
PREVENTCKD. ENHANCEMENT OF PREVENTION OF CHRONIC KIDNEY DISEASE IN THE EU: A TARGETED APPROACH TO TAKING ACTION |
ORTIZ ARDUAN, ALBERTO |
CLINICAL RESEARCH PROJECTS. INTERNATIONAL |
€98,223.86 |
|
PICKED |
PICKED: PERSONALIZED MEDICINE IN CHRONIC KIDNEY DISEASE |
SANCHEZ NIÑO, DOLORES |
CLINICAL RESEARCH PROJECTS. INTERNATIONAL |
€251,971.20 |
|
CB16/11/00333 |
GRUPO DE INVESTIGACION DEL CIBER DE ENFERMEDADES CARDIOVASCULARES |
BLANCO COLIO, LUIS MIGUEL |
CIBER |
€0.00 |
|
CB07/08/2007 |
GRUPO DE INVESTIGACION DEL CIBER DE DIABETES Y ENFERMEDADES METABÓLICAS ASOCIADAS (CIBERDEM) |
EGIDO DE LOS RIOS, JESUS |
CIBER |
€0.00 |
|
PI22/00233 |
DESCIFRANDO EL PAPEL DE LAS ANEXINAS EN EL REMODELADO PATOLÓGICO DE LA PARED VASCULAR: BÚSQUEDA DE NUEVAS DIANAS DIAGNÓSTICAS Y/O TERAPÉUTICAS |
BLANCO COLIO, LUIS MIGUEL |
CLINICAL RESEARCH PROJECTS. ISCIII |
€177,870.00 |
|
PI23/00119 |
EL PAPEL DE LA INFLAMACIÓN EN LA PREVENCIÓN DE LA DIABETES TIPO 2 Y SUS COMPLICACIONES. LA MODULACIÓN DE LAS VÍAS DE SEÑALIZACIÓN INFLAMATORIAS COMO TERAPIA AÑADIDA A LOS NUEVOS FÁRMACOS ANTIDIABÉTICOS. |
EGIDO DE LOS RIOS, JESUS |
CLINICAL RESEARCH PROJECTS. ISCIII |
€252,500.00 |
|
PI23/00627 |
ADN LIBRE COMO BIOMARCADOR Y DIANA TERAPEUTICA EN ENFERMEDAD RENAL DIABÉTICA: DIFERENCIAS DE GÉNERO |
FERNANDEZ FERNANDEZ, BEATRIZ |
CLINICAL RESEARCH PROJECTS. ISCIII |
€83,750.00 |
|
PI21/01430 |
PROFUNDIZACIÓN DEL ESTUDIO DEL IMPACTO DE LAS TOXINAS URÉMICAS AROMÁTICAS Y LOS BISFENOLES EN PACIENTES CON ENFERMEDAD RENAL CRÓNICA (ERC). PAPEL EN LA PROGRESIÓN Y ESTRATEGIAS CONTRA ESTE CÍRCULO VICIOSO |
GONZALEZ PARRA, EMILIO JOSE |
CLINICAL RESEARCH PROJECTS. ISCIII |
€99,220.00 |
|
PI24/01630 |
MOVILIZANDO LAS TOXINAS URÉMICAS UNIDAS A PROTEÍNAS EN PACIENTES EN DIÁLISIS: HACIA UNA MEJORÍA EN LOS RESULTADOS CLÍNICOS |
GONZALEZ PARRA, EMILIO JOSE |
CLINICAL RESEARCH PROJECTS. ISCIII |
€215,000.00 |
|
PI21/01126 |
NUEVOS MEDIADORES DE LA COMUNICACIÓN CELULAR ENDOTELIOMUSCULO LISO EN PATOLOGÍAS DE REMODELADO VASCULAR. ESTUDIO TRANSLACIONAL |
MENDEZ BARBERO, NEREA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€141,570.00 |
|
PI24/00180 |
DESCIFRANDO EL DIÁLOGO CELULAR EN LA PARED VASCULAR: CLAVE PARA LA BÚSQUEDA DE NUEVAS DIANAS DIAGNÓSTICAS Y/O TERAPÉUTICAS DEL REMODELADO VASCULAR PATOLÓGICO. |
MENDEZ BARBERO, NEREA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€152,500.00 |
|
ICI24/00034 |
TERAPIA CON CÉLULAS CAR-TCD19 EN NEFRITIS LÚPICA REFRACTARIA (CART-NEL) |
ORTIZ ARDUAN, ALBERTO |
CLINICAL RESEARCH PROJECTS. ISCIII |
€1,401,180.00 |
|
PI22/00050 |
PROMOVIENDO LAS DEFENSAS ENDÓGENAS FRENTE A LA ENFERMEDAD RENAL |
ORTIZ ARDUAN, ALBERTO |
CLINICAL RESEARCH PROJECTS. ISCIII |
€280,720.00 |
|
PMP21/00109 |
SPAIN CKD CAUSE (SPACKDC) |
ORTIZ ARDUAN, ALBERTO |
CLINICAL RESEARCH PROJECTS. ISCIII |
€2,609,200.00 |
|
RD21/0005/0001 |
RED: RICORS2040 INFLAMACIÓN E INMUNOPATOLOGÍA DE ÓRGANOS Y SISTEMAS |
ORTIZ ARDUAN, ALBERTO |
COLLABORATION NETWORKS. ISCIII |
€270,765.00 |
|
RD24/0004/0001 |
RICORS2040-RENAL |
ORTIZ ARDUAN, ALBERTO |
COLLABORATION NETWORKS. ISCIII |
€389,983.00 |
|
PI22/01168 |
IDENTIFICACIÓN DE BIOMARCADORES DE RIESGO RENAL EN LA ENFERMEDAD DE ALPORT |
PEREZ GOMEZ, MARIA VANESSA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€81,070.00 |
|
PMP22/00119 |
RED NACIONAL DE LABORATORIOS DE FUNCIÓN RENAL |
PEREZ GOMEZ, MARIA VANESSA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€42,900.00 |
|
PI21/01453 |
FUNCIÓN MITOCONDRIAL E INFLAMACIÓN EN EL CURSO DEL FRACASO RENAL AGUDO. PAPEL DE PROTEÍNAS UNIDORAS DE ÁCIDOS GRASOS (FABP) Y DE DSBL- A EN NEFROPROTECCIÓN. |
RAMOS CORTASSA, ADRIAN MARIO |
CLINICAL RESEARCH PROJECTS. ISCIII |
€147,620.00 |
|
PI24/00007 |
NUEVOS BIOMARCADORES Y DIANAS TERAPÉUTICAS EN LA COMUNICACIÓN GLOMERULAR CÉLULA-CÉLULA EN LA GLOMERULONEFRITIS CRESCENTE |
RAYEGO MATEOS, SANDRA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€171,250.00 |
|
PI23/00394 |
ENFERMEDAD RENAL CRÓNICA Y SENESCENCIA CELULAR: BUSCANDO LA CONEXIÓN PARA ENTENDER EL DAÑO RENAL Y EL ENVEJECIMIENTO |
RUIZ ORTEGA, MARTA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€277,500.00 |
|
RD21/0005/0002 |
RED: RICORS2040 INFLAMACIÓN E INMUNOPATOLOGÍA DE ÓRGANOS Y SISTEMAS |
RUIZ ORTEGA, MARTA |
COLLABORATION NETWORKS. ISCIII |
€105,765.00 |
|
RD24/0004/0021 |
RICORS2040-RENAL |
RUIZ ORTEGA, MARTA |
COLLABORATION NETWORKS. ISCIII |
€138,303.00 |
|
PI21/00251 |
CONSERVANDO LA EXPRESIÓN DE KLOTHO PARA RETRASAR EL ENVEJECIMIENTO RENAL |
SANCHEZ NIÑO, DOLORES |
CLINICAL RESEARCH PROJECTS. ISCIII |
€244,420.00 |
|
PI24/00079 |
APROXIMACIONES TERAPÉUTICAS PARA RETRASAR EL ENVEJECIMIENTO RENAL ACELERADO |
SANCHEZ NIÑO, DOLORES |
CLINICAL RESEARCH PROJECTS. ISCIII |
€227,500.00 |
|
PI22/00469 |
NUEVOS ABORDAJES DIAGNÓSTICOS Y TERAPÉUTICOS PARA PREVENIR LA MUERTE CELULAR E INFLAMACIÓN ACTIVADOS POR RIPK1 Y RIPK3 EN EL FRACASO RENAL AGUDO. |
SANZ BARTOLOME, ANA BELEN |
CLINICAL RESEARCH PROJECTS. ISCIII |
€208,120.00 |
|
PID2021-127741OB-I00 |
REGULACIÓN DE INTERACCIONES MICRORNA-MRNA Y PROTEÍNA-PROTEÍNA EN DIABETES Y ENFERMEDADES METABÓLICAS ASOCIADAS: IMPLICACIONES PATOLÓGICAS Y TERAPÉUTICAS. |
GOMEZ GUERRERO, CARMEN |
INNOVATION PROJECTS. MINISTRY |
€205,700.00 |
|
PID2022-136979OB-I00 |
MODULACIÓN DE LA GLICOSILACIÓN PARA PREVENIR EL REMODELADO VASCULAR PATOLÓGICO (GLYVASC) |
MARTIN VENTURA, JOSE LUIS |
CLINICAL RESEARCH PROJECTS. MINISTRY |
€325,000.00 |
|
PID2022-137730OA-I00 |
NUEVAS DIANAS TERÁPEUTICAS METABÓLICAS EN AORTOPATÍAS |
OLLER PEDROSA, JORGE |
CLINICAL RESEARCH PROJECTS. MINISTRY |
€193,750.00 |
|
S2022/BMD-7223 |
CONSORCIO PARA EL ESTUDIO DEL FRACASO RENAL Y SU IMPACTO EN LA PATOLOGIA CARDIOVASCULAR |
ORTIZ ARDUAN, ALBERTO |
CLINICAL RESEARCH PROJECTS. CAM |
€75,440.00 |
|
FI20/00265 |
CONTRATO PFIS: RAFAEL BLÁZQUEZ SERRA |
BLANCO COLIO, LUIS MIGUEL |
PREDOCTORAL RESEARCH. ISCIII |
€82,400.00 |
|
CP19/00151 |
IDENTIFICATION AND VALIDATION OF NEW TARGETS FOR THE DIAGNOSIS AND TREATMENT OF PATHOLOGICAL VASCULAR REMODELING OBTAINED BY RNA-SEQUENCING. ROLE OF ANXA8. |
MENDEZ BARBERO, NEREA |
POSTDOCTORAL. RESEARCH. ISCIII |
€242,500.00 |
|
FI22/00140 |
CONTRATO PFIS: MARÍA JOSÉ FERNÁNDEZ GÓMEZ |
MENDEZ BARBERO, NEREA |
PREDOCTORAL RESEARCH. ISCIII |
€119,567.00 |
|
FI23/00154 |
CONTRATO PFIS: CARLA MAYA LÓPEZ |
PEREZ GOMEZ, MARIA VANESSA |
PREDOCTORAL RESEARCH. ISCIII |
€119,567.00 |
|
CP23/00025 |
CONTRATO MIGUEL SERVET: SANDRA RAYEGO MATEOS. NUEVO BIOMARCAORES Y OBJETIVOS TERAPÉURTICOS EN LA COMUNICACIÓN CELULAR EN ENFERMEDADES RENALES |
RAYEGO MATEOS, SANDRA |
POSTDOCTORAL. RESEARCH. ISCIII |
€308,600.00 |
|
CD23/00049 |
CONTRATO SARA BORRELL: FÁTIMA RAQUEL MILHANO DOS SANTOS |
RUIZ ORTEGA, MARTA |
POSTDOCTORAL. RESEARCH. ISCIII |
€95,000.00 |
|
RYC2021-033343-I |
CONTRATO RYC: JORGE OLLER PEDROSA |
OLLER PEDROSA, JORGE |
POSTDOCTORAL. RESEARCH. MINISTRY |
€236,350.00 |
|
FPU22/01519 |
CONTRATO FORMACIÓN PROFESORADO UNIVERSITARIO: NATALIA VILLAR GÓMEZ |
SANZ BARTOLOME, ANA BELEN |
PREDOCTORAL RESEARCH. MINISTRY |
€81,800.74 |
|
RYC2019-026916-I |
CONTRATO RYC: ANA BELÉN SANZ BARTOLOMÉ |
SANZ BARTOLOME, ANA BELEN |
POSTDOCTORAL. RESEARCH. MINISTRY |
€308,600.00 |
PRIVATE
|
REFERENCE |
PROJECT TITLE |
PRINCIPAL RESEARCHER |
TYPE OF PROJECT |
|
5280/006 |
PAPEL DE LA ANEXINA A6 EN EL DESARROLLO, PROGRESIÓN Y CALCIFICACIÓN DE LA LESIÓN ATEROSCLERÓTICA. |
BLANCO COLIO, LUIS MIGUEL |
RESEARCH PROJECTS. COMPETITIVE |
|
217310/001 |
ROLE OF IMMUNOGLOBULIN A DURING VASCULAR REMODELING AND METABOLIC DISEASE |
MARTIN VENTURA, JOSE LUIS |
RESEARCH PROJECTS. COMPETITIVE |
|
HR22-00253 |
HARNESSING THE ADAPTIVE IMMUNE RESPONSE IN VASCULAR PATHOLOGIES: TOWARDS THE IDENTIFICATION OF NEW THERAPEUTIC AVENUES |
MARTIN VENTURA, JOSE LUIS |
RESEARCH PROJECTS. COMPETITIVE |
|
232755/001 |
NUEVOS TRATAMIENTOS PARA EL SÍNDROME DE MARFAN. |
OLLER PEDROSA, JORGE |
RESEARCH PROJECTS. COMPETITIVE |
|
232755/002 |
PAPEL DEL METABOLISMO EN EL SÍNDROME DE MARFAN (METAMARFAN) |
OLLER PEDROSA, JORGE |
RESEARCH PROJECTS. COMPETITIVE |
|
08172/005 |
PRESERVING KLOTHO EXPRESSION TO DELAY KIDNEY AGING |
SANCHEZ NIÑO, DOLORES |
RESEARCH PROJECTS. COMPETITIVE |
|
9749/006 |
IDENTIFICACIÓN Y CARACTERIZACIÓN DE NUEVOS MEDIADORES DE DAÑO RENAL DEPENDIENTES DE RIPK3 |
SANZ BARTOLOME, ANA BELEN |
RESEARCH PROJECTS. COMPETITIVE |
|
9749/007 |
UTILIDAD DE LA HUELLA MOLECULAR BASADA EN VESÍCULAS EXTRACELULARES CIRCULANTES PARA DETERMINAR LA AFECTACIÓN CARDIORRENAL EN PACIENTES CON DM2 |
SANZ BARTOLOME, ANA BELEN |
RESEARCH PROJECTS. COMPETITIVE |
|
7218107/003 |
ESTUDIO DEL EFECTO DE LA ADMINISTRACIÓN ORAL DE LPC-EPA EN UN MODELO MURINO DE ATEROSCLEROSIS |
GOMEZ GUERRERO, CARMEN |
RESEARCH PROJECTS |
|
2024.075 |
SUPER"GAL-1 TREATMENT IN ATHEROSCLEROTIC PLAQUE REGRESSION AND/OR STABILIZATION |
MARTIN VENTURA, JOSE LUIS |
RESEARCH PROJECTS |
|
4390/017 |
MEDICAL SCIENTIFIC ADVISORY BOARD AGREEMENT |
ORTIZ ARDUAN, ALBERTO |
RESEARCH PROJECTS |
|
4390/025 |
TEGER – PROYECTO ESTRATÉGICO DE I+D (2024-2025-2026) |
ORTIZ ARDUAN, ALBERTO |
RESEARCH PROJECTS |
|
9749/008 |
PRESTACIÓN DE SERVICIOS: DETERMINACIONES LABORATORIO CENTRAL PROYECTO UTILIDAD DEL PROTOCOLO VEXUS EN EL AJUSTE DE PESO IDEAL DE LOS PACIENTES EN HEMODIÁLISIS |
SANZ BARTOLOME, ANA BELEN |
RESEARCH PROJECTS |
|
1547/001 |
DISPOSICIÓN DE UN DIETISTA EN EL SERVICIO DE NEFROLOGÍA DEL HOSPITAL GENERAL DE VILLALBA |
SANCHEZ HERNANDEZ, ROSA |
PERSONNEL/HUMAN RESOURCE |
|
4390/016 |
HYPERKALEMIA IN ROUTINE CLINICAL PRACTICE: A RETROSPECTIVE COHORT STUDY AIMED TO SET UP A MONITORING TOOL OF THE INCIDENCE AND PREVALENCE OF HYPERKALEMIA IN 4 PUBLIC HOSPITALS IN MADRID DURING 1 YEAR-PERIOD, USING ELECTRONIC MEDICAL RECORDS |
ORTIZ ARDUAN, ALBERTO |
OBSERVATIONAL STUDIES |
|
EOH053-24_FJD |
ESTUDIO OBSERVACIONAL MULTICÉNTRICO PARA COMPARAR LAS RECOMENDACIONES DE MÉDICOS Y LAS DECISIONES DE AUTO-MEDICACIÓN DE PACIENTES EN EL USO DE TADALAFILO PARA EL TRATAMIENTO DE LA DISFUNCIÓN ERÉCTIL |
ORTIZ ARDUAN, ALBERTO |
OBSERVATIONAL STUDIES |
|
EOH060-24_FJD |
ESTUDIO POSAUTORIZACIÓN DE SEGURIDAD (EPAS) OBSERVACIONAL EN EUROPA PARA DETERMINAR Y CUANTIFICAR CON MÁS DETALLE EL PERFIL DE SEGURIDAD A LARGO PLAZO DEL USO DE LA VOCLOSPORINA RESPECTO A LA NEUROTOXICIDAD, LA NEFROTOXICIDAD CRÓNICA Y LAS NEOPLASIAS MALIGNAS |
ORTIZ ARDUAN, ALBERTO |
OBSERVATIONAL STUDIES |
|
EOH077-21_FJD |
PREVALENCIA DE FRAGILIDAD EN PACIENTES CON ENFERMEDAD RENAL CRÓNICA EN LISTA DE ESPERA DE TRASPLANTE RENAL EN ESPAÑA: UN ESTUDIO MULTICÉNTRICO |
RAMOS VERDE, ANA MARIA |
OBSERVATIONAL STUDIES |
|
PIC022-25_FJD |
EFECTOS DE LA SUPLEMENTACIÓN NUTRICIONAL ORAL ESPECIFICA (100% LACTOPROTEÍNA SÉRICA HIDROLIZADA Y ALTO APORTE DE MCT) EN PACIENTE ONCOLÓGICO SOMETIDO A RADIOTERAPIA, DESNUTRIDO O EN RIESGO DE DESNUTRICIÓN. ESTUDIO NORMA |
DASSEN DE MONZO, MARIA CAROLINA |
RESEARCH PROJECTS |
|
PIC187-22_FJD |
SEGUIMIENTO DE LAS VÍAS DE TRATAMIENTO EN PACIENTES ADULTOS CON HIPERPOTASIEMIA (TRACK). ESTUDIO LONGITUDINAL, PROSPECTIVO Y NO INTERVENCIONISTA DEL PROCESO DE TRATAMIENTO DE PACIENTES ADULTOS CON HIPERPOTASIEMIA |
ORTIZ ARDUAN, ALBERTO |
RESEARCH PROJECTS |
|
PIC035-25_FJD |
ESTUDIO PARA DETERMINAR LA PREVALENCIA Y LAS CARACTERÍSTICAS CLÍNICAS ASOCIADAS A LOS GRUPOS DE VARIANTES GENÉTICAS DE PKD1 EN LA POLIQUISTOSIS RENAL AUTOSÓMICA DOMINANTE (PQRAD) |
PEREZ GOMEZ, MARIA VANESSA |
RESEARCH PROJECTS |
|
00400053 |
PRÁCTICAS FORMACIÓN EN CENTROS DE TRABAJO (FCT) |
LORENZO GONZALEZ, OSCAR |
TRAINING/TEACHING |
|
00400052 |
FORMACIÓN PRÁCTICA DE ALUMNOS/AS DEL GRADO DE BIOMEDICINA Y BIOTECNOLOGÍA DE LA UNIVERSIDAD ALFONSO X EL SABIO |
MENDEZ BARBERO, NEREA |
TRAINING/TEACHING |
|
00400066 |
HD SPOTLIGHT WEBINARS: BLOOD-INCOMPATIBILITY IN HAEMODIALYSIS: ALLEVIATING INFLAMMATION AND EFFECTS OF COAGULATION (OCTOBER 22ND, 2025) |
ORTIZ ARDUAN, ALBERTO |
TRAINING/TEACHING |
|
2024.096 |
HIGH-VOLUME HEMODIAFILTRATION MEDICALSCIENTIFIC ADVISORY BOARD |
ORTIZ ARDUAN, ALBERTO |
TRAINING/TEACHING |
|
00400054 |
PRÁCTICAS FORMACIÓN EN CENTROS DE TRABAJO (FCT) |
PINTOR CHOCANO, ARANZAZU |
TRAINING/TEACHING |
|
00400062 |
JORNADA "TECH DAY": CENTRADA EN LAS TÉCNICAS DE SINGLE CELL Y SPATIAL TRANSCRIPTOMICS. CHARLA 10X (22 DE SEPTIEMBRE DE 2025) |
SANZ BARTOLOME, ANA BELEN |
TRAINING/TEACHING |
|
00400042 |
I JORNADA DE ACTUALIZACIÓN EN MENOPAUSIA PARA ESPECIALISTAS EN ENDOCRINOLOGÍA Y NUTRICIÓN: LA MENOPAUSIA: ENCRUCIJADA HORMONO METABÓLICA (3 DE ABRIL DE 2025) |
VAZQUEZ MARTINEZ, CLOTILDE |
TRAINING/TEACHING |
Clinical trials
The clinical trials listed below were in the recruitment phase in 2025. If you are interested in participating in any of the currently open trials, more information is available on the website (https://ensayos.quironsalud.es/)
|
EudraCT Number |
TITLE |
PHASE |
MC1 |
INT2 |
PRINCIPAL RESEARCHER |
|
2024-516095-15-00 |
A RANDOMISED, DOUBLE BLIND, PLACEBO-CONTROLLED, SINGLE ASCENDING DOSE, PHASE 1A/1B MULTI-CENTRE STUDY IN HEALTHY PARTICIPANTS AND PARTICIPANTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF GSK4771261A |
I |
YES |
YES |
MARIA VANESSA PEREZ GOMEZ |
|
2021-003037-11 |
ESTUDIO EN FASE II, DE GRUPOS PARALELOS, DOBLE CIEGO Y CON TRES GRUPOS DE TRATAMIENTO, PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE FINERENONA MÁS EMPAGLIFLOZINA EN COMPARACIÓN CON FINERENONA O EMPAGLIFLOZINA EN PARTICIPANTES CON ENFERMEDAD RENAL CRÓNICA Y DIABETES TIPO 2. |
II |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2023-505755-40-00 |
(22040 ALPINE 1) A PHASE 2B DOSE-FINDING, RANDOMIZED, PLACEBOCONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE EFFICACY AND SAFETY OF BAY 3283142 ON TOP OF STANDARD OF CARE IN REDUCING ALBUMINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
II |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2024-510846-15-00 |
EFFICACY, SAFETY, AND PHARMACOKINETICS OF NNC0519-0130 ONCE WEEKLY S.C. VERSUS SEMAGLUTIDE 1.0 MG AND PLACEBO IN PEOPLE WITH CHRONIC KIDNEY DISEASE, WITH OR WITHOUT TYPE 2 DIABETES, AND WITH OVERWEIGHT OR OBESITY: A PROOF-OF-CONCEPT AND DOSE-FINDING STUDY |
II |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2024-511775-15-00 |
ESTUDIO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE FREXALIMAB, SAR442970 O RILZABRUTINIB EN PARTICIPANTES DE 16 A 75 AÑOS CON GLOMERULOESCLEROSIS FOCAL SEGMENTARIA PRIMARIA O ENFERMEDAD DE CAMBIOS MÍNIMOS |
II |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2023-506511-17-00 |
ENSAYO PILOTO DOBLE CIEGO CONTROLADO CON PLACEBO, DE BP1.4979 PARA EL TRATAMIENTO DE LA HIPERFAGIA BULÍMICA |
II |
YES |
YES |
CLOTILDE VAZQUEZ MARTINEZ |
|
2024-520322-11-00 |
ESTUDIO EN FASE II, ALEATORIZADO, CONTROLADO CON PLACEBO CON ENMASCARAMIENTO DOBLE Y CON COMPARADOR ACTIVO EN ABIERTO, DE GRUPOS PARALELOS Y MULTICÉNTRICO PARA EVALUAR LA EFICACIA, LA SEGURIDAD Y LA TOLERABILIDAD DE RO7795081 ADMINISTRADO UNA VEZ AL DÍA DURANTE 30 SEMANAS A PARTICIPANTES CON DIABETES MELLITUS DE TIPO 2 |
II |
YES |
YES |
CLOTILDE VAZQUEZ MARTINEZ |
|
2023-505292-73-00 |
A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO |
II |
YES |
YES |
MARIA VANESSA PEREZ GOMEZ |
|
2023-509638-20-00 |
VONAFEXOR FIXED DOSE-ESCALATION SAFETY AND PROOF-OF-CONCEPT STUDY IN PATIENTS WITH AT RISK OF PROGRESSION ALPORT SYNDROME |
II |
YES |
YES |
MARIA VANESSA PEREZ GOMEZ |
|
2024-517143-31-00 |
ESTUDIO EN FASE II, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA SEGURIDAD Y LA EFICACIA |
II |
YES |
YES |
MARIA VANESSA PEREZ GOMEZ |
|
2022-500273-14-00 |
ESTUDIO EN FASE IIB/III, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, COMBINADO DE BÚSQUEDA DE DOSIS Y RESULTADOS CARDIOVASCULARES PARA INVESTIGAR LA EFICACIA Y LA SEGURIDAD DE CSL300 (CLAZAKIZUMAB) EN PACIENTES CON NEFROPATÍA TERMINAL SOMETIDOS A DIÁLISIS |
II/III |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2023-503772-24-00 |
A PHASE 2B/3, MULTI-PART, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ATACICEPT IN SUBJECTS WITH IGA NEPHROPATHY (IGAN) |
II/III |
YES |
NO |
ALBERTO ORTIZ ARDUAN |
|
2017-004605-41 |
ESTUDIO ALEATORIZADO, MULTICÉNTRICO, DOBLE CIEGO, DE GRUPOS PARALELOS Y CONTROLADO CON PRINCIPIO ACTIVO, DE LA EFICACIA Y LA SEGURIDAD DE ESPARSENTÁN PARA EL TRATAMIENTO DE LA NEFROPATÍA POR INMUNOGLOBULINA A |
III |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2021-004174-64 |
ESTUDIO PIVOTAL DE FASE III MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y COMPARADO CON PLACEBO SOBRE LA EFICACIA Y LA SEGURIDAD DE DMX-200 EN PACIENTES CON GLOMERULOESCLEROSIS FOCAL Y SEGMENTARIA (GEFS) QUE ESTÉN EN TRATAMIENTO CON UN ANTAGONISTA DE LOS RECEPTORES DE LA ANGIOTENSINA II (ARA-II) |
III |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2022-501802-36-00 |
ARTEMIS RAVULIZUMAB PARA PROTEGER A LOS PACIENTES CON INSUFICIENCIA RENAL CRÓNICA (IRC) DE SUFRIR UNA LESIÓN RENAL AGUDA ASOCIADA A LA INTERVENCIÓN QUIRÚRGICA CARDÍACA (CSA-AKI) Y ACONTECIMIENTOS RENALES ADVERSOS GRAVES (ARAG) POSTERIORES: ESTUDIO DE FASE III, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO |
III |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2023-506425-12-00 |
MLS-101-301: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL ARM, MULTICENTER PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LORUNDROSTAT IN SUBJECTS WITH UNCONTROLLED AND RESISTANT HYPERTENSION |
III |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2023-506457-38-00 |
A PHASE III, RANDOMISED, DOUBLE -BLIND, ACTIVE-CONTROLLED STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF BAXDROSTAT IN COMBINATION WITH DAPAGLIFLOZIN COMPARED WITH DAPAGLIFLOZIN ALONE ON CHRONIC KIDNEY DISEASE (CKD) PROGRESSION IN PARTICIPANTS WITH CKD AND HIGH BLOOD PRESSURE |
III |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2024-514135-17-00 |
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF POVETACICEPT IN ADULTS WITH IMMUNOGLOBULIN A NEPHROPATHY (RAINIER) |
III |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2024-519345-30-00 |
ESTUDIO DE FASE 3, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO SOBRE EL FELZARTAMAB EN ADULTOS CON NEFROPATÍA POR IGA (PREVAIL) |
III |
YES |
YES |
ALBERTO ORTIZ ARDUAN |
|
2019-004183-21 |
UN ESTUDIO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE XYLOCORE, UNA SOLUCIÓN EXPERIMENTAL AHORRADORA DE GLUCOSA, PARA DIÁLISIS PERITONEAL |
III |
YES |
YES |
CATALINA MARTIN CLEARY |
|
2022-500817-14-00 |
ESTUDIO DE FASE 3, ALEATORIZADO, DOBLE CIEGO, COMPARATIVO CON UN PLACEBO, PARA INVESTIGAR EL EFECTO DE TIRZEPATIDA SOBRE LA REDUCCIÓN DE LA MORBIMORTALIDAD EN ADULTOS CON OBESIDAD |
III |
YES |
YES |
CLOTILDE VAZQUEZ MARTINEZ |
|
2021-003062-12 |
A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF LIXIVAPTAN IN PARTICIPANTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE CONSISTING OF A 1-YEAR DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE AND A 1-YEAR OPEN-LABEL PHASE: THE ACTION STUDY. |
III |
YES |
YES |
MARIA VANESSA PEREZ GOMEZ |
|
2022-500210-26-00 |
HYDROCHLOROTHIAZIDE TO PROTECT POLYCYSTIC KIDNEY DISEASE PATIENTS AND IMPROVE THEIR QUALITY OF LIFE (HYDRO-PROTECT) |
III |
YES |
YES |
MARIA VANESSA PEREZ GOMEZ |
|
2023-505868-11-00 |
EFFICACY OF COLCHICINE IN SECONDARY PREVENTION OF VASCULAR EVENTS AND RENAL PROGRESSION IN PATIENTS WITH MODERATE CHRONIC RENAL DISEASE (COLCHIREN STUDY) |
III |
YES |
NO |
MARIA VANESSA PEREZ GOMEZ |
|
NA |
ANÁLISIS DE NECESIDADES PSICOSOCIALES EN PACIENTES CON ENFERMEDAD RENAL CRÓNICA E INTERVENCIÓN PSICOLÓGICA BASADA EN LA TERAPIA DE ACEPTACIÓN Y COMPROMISO (ACT) (ENSAYO CLÍNICO ALEATORIZADO). |
NA |
YES |
NO |
EMILIO JOSE GONZALEZ PARRA |
|
NA |
ESTUDIO ALEATORIZADO, CRUZADO, PARA COMPARAR LAS MODIFICACIONES DEL BPA SÉRICO DE 3 MEMBRANAS PARA HEMODIÁLISIS |
NA |
YES |
NO |
EMILIO JOSE GONZALEZ PARRA |
|
NA |
ESTUDIO DEL IMPACTO DE LA COMBINACIÓN DE LA MICRONUTRICIÓN BÁSICA Y LA ALIMENTACIÓN BAJA EN PROTEÍNAS EN LA MEJORA DE LA INSUFICIENCIA RENAL CRÓNICA DE GRADO IIIA, IIIB O IV |
NA |
YES |
NO |
MIGUEL AGANZO YEVES |
|
NA |
ENSAYO ALEATORIZADO DE NO INFERIORIDAD PARA EVALUAR UN CONSEJO DE CONSUMO MODERADO DE ALCOHOL FRENTE A UN CONSEJO DE ABSTENCIÓN |
NA |
YES |
YES |
ROSA SANCHEZ HERNANDEZ |
|
MC1: MULTICENTRE INT2: INTERNATIONAL |
|||||
Patents (revisar)
Title: Composición farmacéutica y su uso para la fabricación de un medicamento para el tratamiento de la enfermedad renal crónica y método de selección de compuestos.
Application No: P201430081
Main entities: FIIS-FJD (80%), IdiPaz (20%)
Inventors: Alberto Ortiz Arduán, Mª Dolores Sánchez Niño.
Title: Péptido derivado de SOCS1 para su uso en complicaciones crónicas de la diabetes.
Application No: P201430796
Main entities: VHIR (49%), IIS-FJD (26%), UAM (25%)
Inventors: Jesús Egido de los Ríos; Carmen Gómez Guerrero.
Title: SOCS1-derived peptide for use in chronic complications relating to diabetes.
Application No: PCT/ES2015/070415
Main entities: VHIR (49%), IIS-FJD (26%), UAM (25%)
Inventors: Jesús Egido de los Ríos; Carmen Gómez Guerrero; Rafael Simó Canonge; Cristina Hernández Pascual.
Title: Uso de la pentoxifilina y de una composición farmacéutica para elaborar un medicamento para prevenir el envejecimiento prematuro en humanos.
Application No: P201530616
Main entities: IIS-FJD (75%), Hospital Universitario Nuestra Sa. De Candelaria (25%)
Inventors: Alberto Ortiz Arduán, Dolores Sánchez Niño, Ana Belén Sanz Bartolomé, Juan Francisco Navarro González.
Title: Uso de una composicion farmaceutica para la fabricacion de un medicamento para el tratamiento y/o la prevencion del dano renal agudo.
Application No: P201531328
Main entities: FIIS-FJD (90%), CBMSO (10%)
Inventors: Alberto Ortiz Arduán, Dolores Sánchez Niño, Manuel Fresno.
Title: Derivados del crotonato para la fabricación de un medicamento para el tratamiento de enfermedad renal crónica y fracaso renal agudo.
Application No: P201531677
Main entities: FIIS-FJD (100%)
Inventors: Alberto Ortiz Arduán, Dolores Sánchez Niño, Ana Belén Sanz Bartolomé, Olga Ruiza Andrés.
Title: Elaboración de un medicamento para prevenir el envejecimiento prematuro en humanos, composición farmacéutica y método de selección de compuestos basado en el uso de siRNA de NFKbiz.
Application No: P201531933
Main entities: FIIS-FJD (100%)
Inventors: Alberto Ortiz Arduán, Dolores Sánchez Niño, Ana Belén Sanz Bartolomé, Jonay Poveda.
Title: Composición farmacéutica que comprende un vector en el que se ha clonado el gen de BCL3, uso de la misma y vector.
Application No: P201631183
Main entities: FIIS-FJD (100%)
Inventors: Alberto Ortiz Arduán, Dolores Sánchez Niño, Ana Belén Sanz Bartolomé, Jonay Poveda.
Title: GDF15 en orina como biomarcador de daño renal.
Application No: P201830849
Main entities: FIIS-FJD (100%)
Inventors: Alberto Ortiz Arduán, Dolores Sánchez Niño, Ana Belén Sanz Bartolomé, María Vanessa Pérez Gomez, Beatriz Fernández Fernández.
Title: In vitro method for detecting renal disease.
Application No: EP19382470.3
Main entities: FIIS-FJD (60%); UAM (40%)
Inventors: D. Alberto Ortiz Arduán, Emilio Gonzalez-Parra, Jesus Egido de los Ríos, Marta Ruiz-Ortega, Sandra Rayego-Mateos, José Luis Morgado Pascual.
Title: SOCS1 derived peptides for use in the treatment of liver diseases.
Application No: EP22383040.7
Main entities: FIIS-FJD (74%), UAM (26%)
Inventors: Jesus Egido De Los Ríos, Carmen Gómez Guerrero, Sebastián Mas Fontao, Manuel Soto Catalán, Daniela Marasco, Sara La Manna, Susana Bernal Uribe, Lucas Opazo Ríos, Ignacio Prieto Arroyo, Laura López Sanz, Luna Jiménez Castilla.
Title: SOCS1 derived peptides for use in the treatment of liver diseases.
Application No: PCT/EP2023/079934
Main entities: FIIS-FJD (74%), UAM (26%)
Inventors: Jesus Egido De Los Ríos, Carmen Gómez Guerrero, Sebastián Mas Fontao, Manuel Soto Catalán, Daniela Marasco, Sara La Manna, Susana Bernal Uribe, Lucas Opazo Ríos, Ignacio Prieto Arroyo, Laura López Sanz, Luna Jiménez Castilla.
Title: HBS - method for the diagnosis of aneurysm, and inhibitors for use in the prevention or treatment of aneurysm.
Application No: EP23383195.7
Main entities: FIIS-FJD (50%), CSIC (50%)
Inventors: María Mittelbrum, Jorge Oller Pedrosa.










